,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2019-09-11 13:32:28,2019-09-09,PGNX,"Velan Capital, L.P.","See Explanation of Responses, 10%",P - Purchase,$4.99,72023,8011733,+1%,"+$359,733",,,,,PGNX
1,M,2019-09-09 18:14:16,2019-09-05,PGNX,"Lte Partners, LLC","See Explanation of Responses, 10%",P - Purchase,$4.73,65000,1950000,+3%,"+$307,193",,,,,PGNX
2,M,2019-09-05 16:37:12,2019-09-03,PGNX,"Velan Capital, L.P.","See Explanation of Responses, 10%",P - Purchase,$4.45,521038,7939710,+7%,"+$2,317,446",,,,,PGNX
3,M,2019-08-27 15:45:49,2019-08-23,PGNX,"Velan Capital, L.P.","See Explanation of Responses, 10%",P - Purchase,$4.31,204056,7418672,+3%,"+$878,601",,,,,PGNX
4,D,2019-07-08 12:32:54,2019-07-03,PGNX,Campbell Bradley L,Dir,M - OptEx,$4.89,12000,12000,New,"+$58,680",,,,,PGNX
5,D,2019-07-03 08:56:13,2019-07-01,PGNX,Scheinberg David A,Dir,M - OptEx,$5.33,10000,56185,+22%,"+$53,300",,,,,PGNX
6,D,2019-06-27 16:33:41,2019-06-26,PGNX,Crowley Peter J,Dir,M - OptEx,$5.35,50000,50000,New,"+$267,300",,,,,PGNX
7,M,2017-02-15 17:13:38,2017-02-13,PGNX,Broadfin Healthcare Master Fund Ltd,10%,S - Sale,$9.66,-602600,6997269,-8%,"-$5,819,720",10.0,5.0,19.0,,PGNX
8,M,2017-02-09 16:40:14,2017-02-07,PGNX,Broadfin Healthcare Master Fund Ltd,10%,S - Sale,$9.71,-351300,7599869,-4%,"-$3,410,091",-2.0,-1.0,18.0,,PGNX
9,,2017-01-13 16:28:35,2017-01-11,PGNX,Broadfin Healthcare Master Fund Ltd,10%,D - Sale to issuer,$8.95,-1000000,7951169,-11%,"-$8,950,000",-2.0,-1.0,8.0,,PGNX
10,A,2016-04-22 17:09:42,2010-12-01,PGNX,Maddon Paul J,Dir,P - Purchase,$4.90,5000,909891,+1%,"+$24,500",0.0,-1.0,-14.0,0.0,PGNX
11,D,2015-06-15 09:32:37,2015-06-11,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.33,2000,35050,+6%,"+$10,660",3.0,10.0,22.0,-15.0,PGNX
12,D,2015-06-15 09:32:37,2015-06-11,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$6.83,-2000,35050,-5%,"-$13,660",3.0,10.0,22.0,-15.0,PGNX
13,D,2015-03-16 12:26:41,2015-03-13,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.35,3000,35050,+9%,"+$16,050",-13.0,-15.0,-10.0,4.0,PGNX
14,D,2015-03-16 12:26:41,2015-03-13,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$7.00,-3000,35050,-8%,"-$21,000",-13.0,-15.0,-10.0,4.0,PGNX
15,D,2015-03-13 09:26:12,2015-03-11,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.33,2000,35050,+6%,"+$10,660",5.0,-4.0,-8.0,5.0,PGNX
16,D,2015-03-13 09:26:12,2015-03-11,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$6.83,-2000,35050,-5%,"-$13,660",5.0,-4.0,-8.0,5.0,PGNX
17,D,2015-03-04 14:55:15,2015-03-03,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$4.70,5000,35050,+17%,"+$23,500",4.0,-2.0,-13.0,8.0,PGNX
18,D,2015-03-04 14:55:15,2015-03-03,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$6.49,-5000,35050,-12%,"-$32,450",4.0,-2.0,-13.0,8.0,PGNX
19,D,2015-01-13 13:48:01,2015-01-12,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.33,2000,35050,+6%,"+$10,660",-7.0,-9.0,-17.0,19.0,PGNX
20,D,2015-01-13 13:48:01,2015-01-12,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$7.06,-2000,35050,-5%,"-$14,112",-7.0,-9.0,-17.0,19.0,PGNX
21,D,2014-12-12 11:27:57,2014-12-11,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.35,3000,35050,+9%,"+$16,050",2.0,6.0,-9.0,-2.0,PGNX
22,D,2014-12-12 11:27:57,2014-12-11,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$7.07,-3000,35050,-8%,"-$21,201",2.0,6.0,-9.0,-2.0,PGNX
23,D,2014-11-21 17:06:48,2014-11-21,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.35,9000,35050,+35%,"+$48,150",0.0,3.0,4.0,-25.0,PGNX
24,D,2014-11-21 17:06:48,2014-11-21,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$7.00,-9000,35050,-20%,"-$63,000",0.0,3.0,4.0,-25.0,PGNX
25,D,2014-11-14 16:38:27,2014-11-13,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.33,10000,35050,+40%,"+$53,300",1.0,1.0,10.0,-11.0,PGNX
26,D,2014-11-14 16:38:27,2014-11-13,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$6.83,-10000,35050,-22%,"-$68,300",1.0,1.0,10.0,-11.0,PGNX
27,D,2014-11-12 09:31:35,2014-11-11,PGNX,Israel Robert J,"EVP, Medi",M - OptEx,$5.03,5000,35050,+17%,"+$25,150",5.0,4.0,11.0,-10.0,PGNX
28,D,2014-11-12 09:31:35,2014-11-11,PGNX,Israel Robert J,"EVP, Medi",S - Sale+OE,$6.53,-5000,35050,-12%,"-$32,650",5.0,4.0,11.0,-10.0,PGNX
29,M,2014-07-23 10:42:11,2014-07-16,PGNX,Broadfin Healthcare Master Fund Ltd,10%,P - Purchase,$4.60,1625436,8951169,+22%,"+$7,476,168",3.0,3.0,6.0,23.0,PGNX
30,D,2013-07-22 13:16:58,2013-07-18,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,5000,35050,+17%,"+$26,650",2.0,-4.0,-29.0,14.0,PGNX
31,D,2013-07-22 13:16:58,2013-07-18,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-5000,35050,-12%,"-$31,650",2.0,-4.0,-29.0,14.0,PGNX
32,,2013-03-28 09:24:15,2013-03-27,PGNX,Baker Mark Robert,CEO,P - Purchase,$5.32,650,161141,0%,"+$3,458",0.0,-7.0,-11.0,-4.0,PGNX
33,,2013-03-22 17:14:39,2013-03-22,PGNX,Scheinberg David A,Dir,M - OptEx,$3.64,2500,46185,+6%,"+$9,098",1.0,6.0,-6.0,7.0,PGNX
34,,2013-02-28 17:24:11,2013-02-27,PGNX,Baker Mark Robert,CEO,P - Purchase,$2.72,1262,160491,+1%,"+$3,434",6.0,18.0,102.0,113.0,PGNX
35,,2013-01-23 09:59:44,2013-01-22,PGNX,Baker Mark Robert,CEO,P - Purchase,$2.82,1215,159229,+1%,"+$3,429",4.0,5.0,-4.0,113.0,PGNX
36,,2012-12-26 13:05:16,2012-12-26,PGNX,Baker Mark Robert,CEO,P - Purchase,$3.01,1142,158014,+1%,"+$3,437",-3.0,9.0,-3.0,47.0,PGNX
37,,2012-11-30 12:07:10,2012-11-28,PGNX,Baker Mark Robert,CEO,P - Purchase,$2.13,1607,156872,+1%,"+$3,419",4.0,3.0,32.0,81.0,PGNX
38,,2012-11-20 13:41:27,2012-11-19,PGNX,Baker Mark Robert,CEO,P - Purchase,$1.96,11800,155265,+8%,"+$23,104",10.0,6.0,40.0,91.0,PGNX
39,,2012-11-19 13:50:03,2012-11-16,PGNX,Baker Mark Robert,CEO,P - Purchase,$1.82,49793,143465,+53%,"+$90,723",10.0,22.0,30.0,116.0,PGNX
40,,2012-11-16 13:54:43,2012-11-15,PGNX,Baker Mark Robert,CEO,P - Purchase,$1.69,48833,93672,+109%,"+$82,332",9.0,37.0,38.0,145.0,PGNX
41,,2012-10-25 11:34:01,2012-10-24,PGNX,Baker Mark Robert,CEO,P - Purchase,$2.96,1162,44839,+3%,"+$3,434",0.0,-5.0,-25.0,59.0,PGNX
42,,2012-09-27 15:14:24,2012-09-26,PGNX,Baker Mark Robert,CEO,P - Purchase,$3.32,1036,43677,+2%,"+$3,440",-1.0,-12.0,-4.0,78.0,PGNX
43,,2012-08-23 09:44:14,2012-08-22,PGNX,Baker Mark Robert,CEO,P - Purchase,$4.23,815,42641,+2%,"+$3,451",0.0,1.0,-20.0,-35.0,PGNX
44,,2012-07-26 11:42:57,2012-07-25,PGNX,Baker Mark Robert,CEO,P - Purchase,$10.04,346,41826,+1%,"+$3,473",5.0,-53.0,-59.0,-71.0,PGNX
45,D,2012-07-03 13:19:36,2012-07-02,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,35050,+3%,"+$5,330",3.0,1.0,-54.0,-69.0,PGNX
46,D,2012-07-03 13:19:36,2012-07-02,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$9.79,-1000,35050,-3%,"-$9,790",3.0,1.0,-54.0,-69.0,PGNX
47,,2012-06-29 09:15:25,2012-06-27,PGNX,Baker Mark Robert,CEO,P - Purchase,$9.27,375,41480,+1%,"+$3,477",7.0,13.0,-41.0,-67.0,PGNX
48,,2012-06-22 15:01:01,2012-06-20,PGNX,Israel Robert J,SVP Medical Affairs,D - Sale to issuer,$8.58,-3333,35050,-9%,"-$28,604",2.0,6.0,16.0,-67.0,PGNX
49,,2012-06-22 15:00:06,2012-06-20,PGNX,Olson William C,"SVP, Research, Develo",D - Sale to issuer,$8.69,-1230,45544,-3%,"-$10,685",2.0,6.0,16.0,-67.0,PGNX
50,D,2012-06-04 16:49:21,2012-06-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",-3.0,2.0,23.0,-73.0,PGNX
51,D,2012-06-04 16:49:21,2012-06-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$8.51,-1000,38383,-3%,"-$8,508",-3.0,2.0,23.0,-73.0,PGNX
52,,2012-05-24 12:38:40,2012-05-23,PGNX,Baker Mark Robert,CEO,P - Purchase,$7.81,445,41105,+1%,"+$3,475",2.0,9.0,11.0,-71.0,PGNX
53,D,2012-05-03 11:25:41,2012-05-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",-2.0,-11.0,-22.0,-74.0,PGNX
54,D,2012-05-03 11:25:41,2012-05-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$10.93,-1000,38383,-3%,"-$10,927",-2.0,-11.0,-22.0,-74.0,PGNX
55,,2012-04-27 09:23:39,2012-04-25,PGNX,Baker Mark Robert,CEO,P - Purchase,$10.07,348,40660,+1%,"+$3,506",3.0,-5.0,-22.0,-73.0,PGNX
56,D,2012-04-03 11:55:08,2012-04-02,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",1.0,-3.0,5.0,-71.0,PGNX
57,D,2012-04-03 11:55:08,2012-04-02,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$9.85,-1000,38383,-3%,"-$9,852",1.0,-3.0,5.0,-71.0,PGNX
58,,2012-03-29 15:12:17,2012-03-28,PGNX,Baker Mark Robert,CEO,P - Purchase,$10.13,343,40312,+1%,"+$3,475",0.0,0.0,12.0,-70.0,PGNX
59,D,2012-03-02 16:29:33,2012-03-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",-4.0,-3.0,5.0,-52.0,PGNX
60,D,2012-03-02 16:29:33,2012-03-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$9.82,-1000,38383,-3%,"-$9,817",-4.0,-3.0,5.0,-52.0,PGNX
61,D,2012-02-27 17:53:03,2012-02-23,PGNX,Scheinberg David A,Dir,M - OptEx,$6.90,1250,46185,+3%,"+$8,625",-1.0,-5.0,1.0,-57.0,PGNX
62,D,2012-02-27 17:53:03,2012-02-23,PGNX,Scheinberg David A,Dir,S - Sale+OE,$10.00,-1250,46185,-3%,"-$12,500",-1.0,-5.0,1.0,-57.0,PGNX
63,,2012-02-23 09:28:38,2012-02-22,PGNX,Baker Mark Robert,CEO,P - Purchase,$9.41,369,39969,+1%,"+$3,474",5.0,2.0,-1.0,-56.0,PGNX
64,,2012-02-03 17:48:49,2012-02-03,PGNX,Briner Kurt W,Dir,S - Sale,$10.22,-33000,0,-100%,"-$337,227",1.0,0.0,-10.0,-53.0,PGNX
65,D,2012-02-02 10:48:04,2012-02-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",3.0,3.0,-5.0,-52.0,PGNX
66,D,2012-02-02 10:48:04,2012-02-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$9.48,-1000,38383,-3%,"-$9,478",3.0,3.0,-5.0,-52.0,PGNX
67,,2012-01-26 10:05:25,2012-01-25,PGNX,Baker Mark Robert,CEO,P - Purchase,$9.53,364,39600,+1%,"+$3,470",-2.0,4.0,6.0,7.0,PGNX
68,M,2012-01-12 13:16:31,2011-10-26,PGNX,Baker Mark Robert,CEO,P - Purchase,$7.51,923,39236,+2%,"+$6,933",0.0,6.0,7.0,14.0,PGNX
69,D,2012-01-04 13:24:49,2012-01-03,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",-1.0,6.0,20.0,23.0,PGNX
70,D,2012-01-04 13:24:49,2012-01-03,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$8.78,-1000,38383,-3%,"-$8,780",-1.0,6.0,20.0,23.0,PGNX
71,D,2011-12-02 14:57:08,2011-12-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",0.0,3.0,21.0,19.0,PGNX
72,D,2011-12-02 14:57:08,2011-12-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.66,-1000,38383,-3%,"-$6,660",0.0,3.0,21.0,19.0,PGNX
73,,2011-11-28 14:18:24,2011-11-23,PGNX,Baker Mark Robert,CEO,S - Sale,$5.45,-634,38313,-2%,"-$3,455",9.0,39.0,73.0,79.0,PGNX
74,D,2011-11-01 17:23:28,2011-11-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",0.0,4.0,7.0,65.0,PGNX
75,D,2011-11-01 17:23:28,2011-11-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-1000,38383,-3%,"-$6,330",0.0,4.0,7.0,65.0,PGNX
76,D,2011-10-05 17:16:19,2011-10-05,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,38383,+3%,"+$5,330",0.0,0.0,1.0,59.0,PGNX
77,D,2011-10-05 17:16:19,2011-10-05,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-1000,38383,-3%,"-$6,330",0.0,0.0,1.0,59.0,PGNX
78,D,2011-10-04 17:24:36,2011-10-03,PGNX,Olson William C,"SVP, Research, Develo",F - Tax,$5.44,-2356,46774,-5%,"-$12,817",-1.0,-1.0,-1.0,69.0,PGNX
79,D,2011-10-04 17:24:36,2011-10-03,PGNX,Olson William C,"SVP, Research, Develo",M - OptEx,$4.62,2605,46774,+6%,"+$12,046",-1.0,-1.0,-1.0,69.0,PGNX
80,D,2011-10-04 17:23:40,2011-10-03,PGNX,McKinney Robert A,"SVP, CFO",F - Tax,$5.44,-2475,44415,-5%,"-$13,464",-1.0,-1.0,-1.0,69.0,PGNX
81,D,2011-10-04 17:23:40,2011-10-03,PGNX,McKinney Robert A,"SVP, CFO",M - OptEx,$4.62,2737,44415,+7%,"+$12,656",-1.0,-1.0,-1.0,69.0,PGNX
82,D,2011-10-04 17:22:48,2011-10-03,PGNX,Israel Robert J,SVP Medical Affairs,F - Tax,$5.44,-3290,38383,-8%,"-$17,898",-1.0,-1.0,-1.0,69.0,PGNX
83,D,2011-10-04 17:22:48,2011-10-03,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$4.62,3638,38383,+10%,"+$16,822",-1.0,-1.0,-1.0,69.0,PGNX
84,D,2011-10-04 17:20:47,2011-10-03,PGNX,Baker Mark Robert,CEO,F - Tax,$5.44,-4666,37679,-11%,"-$25,383",-1.0,-1.0,-1.0,69.0,PGNX
85,D,2011-10-04 17:20:47,2011-10-03,PGNX,Baker Mark Robert,CEO,M - OptEx,$4.62,5124,37679,+16%,"+$23,693",-1.0,-1.0,-1.0,69.0,PGNX
86,,2011-09-28 16:55:58,2011-09-28,PGNX,Baker Mark Robert,CEO,P - Purchase,$6.39,542,37029,+1%,"+$3,463",-1.0,7.0,13.0,64.0,PGNX
87,D,2011-09-28 09:49:45,2011-09-27,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,746,37843,+2%,"+$3,976",-9.0,-2.0,4.0,55.0,PGNX
88,D,2011-09-28 09:49:45,2011-09-27,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-746,37843,-2%,"-$4,722",-9.0,-2.0,4.0,55.0,PGNX
89,D,2011-09-21 12:22:02,2011-09-20,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,100,37843,0%,+$533,-3.0,10.0,11.0,63.0,PGNX
90,D,2011-09-21 12:22:02,2011-09-20,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-100,37843,0%,-$633,-3.0,10.0,11.0,63.0,PGNX
91,D,2011-09-06 14:11:40,2011-09-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,154,37843,0%,+$821,0.0,0.0,14.0,60.0,PGNX
92,D,2011-09-06 14:11:40,2011-09-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-154,37843,0%,-$975,0.0,0.0,14.0,60.0,PGNX
93,,2011-08-25 09:31:53,2011-08-24,PGNX,Baker Mark Robert,CEO,P - Purchase,$6.08,571,36487,+2%,"+$3,472",-3.0,1.0,-4.0,63.0,PGNX
94,D,2011-08-12 11:31:54,2011-08-11,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,37843,+3%,"+$5,330",-9.0,-6.0,-12.0,51.0,PGNX
95,D,2011-08-12 11:31:54,2011-08-11,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$6.33,-1000,37843,-3%,"-$6,330",-9.0,-6.0,-12.0,51.0,PGNX
96,,2011-07-28 17:06:05,2011-07-27,PGNX,Baker Mark Robert,CEO,P - Purchase,$6.12,567,35916,+2%,"+$3,472",-4.0,4.0,5.0,65.0,PGNX
97,D,2011-07-06 18:58:14,2011-07-01,PGNX,McKinney Robert A,"SVP, CFO",F - Tax,$7.40,-6062,43961,-12%,"-$44,859",3.0,4.0,-21.0,15.0,PGNX
98,D,2011-07-06 18:58:14,2011-07-01,PGNX,McKinney Robert A,"SVP, CFO",M - OptEx,$5.46,7279,43961,+20%,"+$39,743",3.0,4.0,-21.0,15.0,PGNX
99,D,2011-07-06 18:57:10,2011-07-01,PGNX,Olson William C,"SVP, Research, Develo",F - Tax,$7.40,-5276,46333,-10%,"-$39,042",3.0,4.0,-21.0,15.0,PGNX
100,D,2011-07-06 18:57:10,2011-07-01,PGNX,Olson William C,"SVP, Research, Develo",M - OptEx,$5.46,6335,46333,+16%,"+$34,589",3.0,4.0,-21.0,15.0,PGNX
101,D,2011-07-06 18:55:59,2011-07-01,PGNX,Israel Robert J,SVP Medical Affairs,F - Tax,$7.40,-6930,37843,-15%,"-$51,282",3.0,4.0,-21.0,15.0,PGNX
102,D,2011-07-06 18:55:59,2011-07-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.45,9322,37843,+33%,"+$50,768",3.0,4.0,-21.0,15.0,PGNX
103,D,2011-07-06 18:55:59,2011-07-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$7.21,-1000,37843,-3%,"-$7,205",3.0,4.0,-21.0,15.0,PGNX
104,D,2011-07-06 18:49:35,2011-07-01,PGNX,Baker Mark Robert,CEO,F - Tax,$7.40,-16905,35349,-32%,"-$125,097",3.0,4.0,-21.0,15.0,PGNX
105,D,2011-07-06 18:49:35,2011-07-01,PGNX,Baker Mark Robert,CEO,M - OptEx,$5.46,20032,35349,+131%,"+$109,375",3.0,4.0,-21.0,15.0,PGNX
106,,2011-06-24 10:07:26,2011-06-22,PGNX,Baker Mark Robert,CEO,P - Purchase,$7.08,490,31922,+2%,"+$3,469",0.0,4.0,-7.0,28.0,PGNX
107,,2011-06-22 16:54:35,2011-06-21,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale,$7.02,-7889,36151,-18%,"-$55,341",0.0,8.0,0.0,-6.0,PGNX
108,,2011-06-22 16:53:46,2011-06-21,PGNX,Olson William C,"SVP, Research, Develo",S - Sale,$7.09,-2872,44974,-6%,"-$20,359",0.0,8.0,0.0,-6.0,PGNX
109,,2011-06-20 11:27:07,2011-06-17,PGNX,McKinney Robert A,"SVP, CFO",S - Sale,$7.50,-3000,42444,-7%,"-$22,500",1.0,-1.0,1.0,1.0,PGNX
110,D,2011-06-02 15:08:51,2011-06-01,PGNX,Israel Robert J,SVP Medical Affairs,M - OptEx,$5.33,1000,44040,+2%,"+$5,330",1.0,-2.0,-8.0,-29.0,PGNX
111,D,2011-06-02 15:08:51,2011-06-01,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale+OE,$8.15,-1000,44040,-2%,"-$8,153",1.0,-2.0,-8.0,-29.0,PGNX
112,,2011-05-26 15:15:12,2011-05-25,PGNX,Baker Mark Robert,CEO,P - Purchase,$7.13,486,31432,+2%,"+$3,465",6.0,6.0,-7.0,-26.0,PGNX
113,M,2011-05-17 15:26:02,2011-05-13,PGNX,Briner Kurt W,Dir,S - Sale,$8.25,-20000,33000,-38%,"-$164,900",-4.0,-9.0,-17.0,-21.0,PGNX
114,D,2011-05-04 15:30:13,2011-05-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,1000,44040,+2%,"+$5,330",-3.0,5.0,2.0,-15.0,PGNX
115,D,2011-05-04 15:30:13,2011-05-02,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$7.39,-1000,44040,-2%,"-$7,390",-3.0,5.0,2.0,-15.0,PGNX
116,,2011-04-27 16:05:26,2011-04-27,PGNX,Baker Mark Robert,CEO,P - Purchase,$7.24,479,30946,+2%,"+$3,468",1.0,5.0,2.0,-11.0,PGNX
117,D,2011-04-05 09:54:12,2011-04-01,PGNX,McKinney Robert A,CFO,F - Tax,$6.29,-2181,45444,-5%,"-$13,718",1.0,9.0,23.0,-11.0,PGNX
118,D,2011-04-05 09:54:12,2011-04-01,PGNX,McKinney Robert A,CFO,M - OptEx,$5.05,2495,45444,+6%,"+$12,600",1.0,9.0,23.0,-11.0,PGNX
119,D,2011-04-05 09:51:26,2011-04-01,PGNX,Baker Mark Robert,Pres,F - Tax,$6.29,-3550,30467,-10%,"-$22,330",1.0,9.0,23.0,-11.0,PGNX
120,D,2011-04-05 09:51:26,2011-04-01,PGNX,Baker Mark Robert,Pres,M - OptEx,$5.05,4022,30467,+15%,"+$20,311",1.0,9.0,23.0,-11.0,PGNX
121,D,2011-04-05 09:50:16,2011-04-01,PGNX,Olson William C,"SVP, Research, Development",F - Tax,$6.29,-2075,47846,-4%,"-$13,052",1.0,9.0,23.0,-11.0,PGNX
122,D,2011-04-05 09:50:16,2011-04-01,PGNX,Olson William C,"SVP, Research, Development",M - OptEx,$5.05,2373,47846,+5%,"+$11,984",1.0,9.0,23.0,-11.0,PGNX
123,D,2011-04-05 09:48:12,2011-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$6.29,-2913,44040,-6%,"-$18,323",1.0,9.0,23.0,-11.0,PGNX
124,D,2011-04-05 09:48:12,2011-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.11,4332,44040,+11%,"+$22,157",1.0,9.0,23.0,-11.0,PGNX
125,D,2011-04-05 09:48:12,2011-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$6.33,-1000,44040,-2%,"-$6,330",1.0,9.0,23.0,-11.0,PGNX
126,D,2011-03-30 16:28:20,2011-03-29,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,800,43377,+2%,"+$4,264",-3.0,-2.0,16.0,1.0,PGNX
127,D,2011-03-30 16:28:20,2011-03-29,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$6.33,-800,43377,-2%,"-$5,064",-3.0,-2.0,16.0,1.0,PGNX
128,D,2011-03-11 17:25:43,2011-03-09,PGNX,Goff Stephen P,Dir,M - OptEx,$1.33,32500,66000,+97%,"+$43,225",-4.0,-4.0,9.0,-7.0,PGNX
129,D,2011-03-09 14:11:56,2011-03-08,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,200,43377,0%,"+$1,066",0.0,-7.0,6.0,-10.0,PGNX
130,D,2011-03-09 14:11:56,2011-03-08,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$6.33,-200,43377,0%,"-$1,266",0.0,-7.0,6.0,-10.0,PGNX
131,D,2011-02-08 16:31:36,2011-02-07,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,7597,43377,+21%,"+$40,492",-2.0,-1.0,4.0,-23.0,PGNX
132,D,2011-02-08 16:31:36,2011-02-07,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$6.33,-7597,43377,-15%,"-$48,089",-2.0,-1.0,4.0,-23.0,PGNX
133,D,2011-01-20 16:11:18,2011-01-19,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,403,43377,+1%,"+$2,148",0.0,7.0,1.0,19.0,PGNX
134,D,2011-01-20 16:11:18,2011-01-19,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$6.33,-403,43377,-1%,"-$2,551",0.0,7.0,1.0,19.0,PGNX
135,D,2011-01-05 16:33:33,2011-01-03,PGNX,McKinney Robert A,CFO,F - Tax,$5.68,-2473,44886,-5%,"-$14,047",-3.0,-2.0,-1.0,30.0,PGNX
136,D,2011-01-05 16:33:33,2011-01-03,PGNX,McKinney Robert A,CFO,M - OptEx,$4.83,2715,44886,+6%,"+$13,108",-3.0,-2.0,-1.0,30.0,PGNX
137,D,2011-01-05 16:32:28,2011-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.68,-3301,43377,-7%,"-$18,750",-3.0,-2.0,-1.0,30.0,PGNX
138,D,2011-01-05 16:32:28,2011-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.83,3625,43377,+9%,"+$17,502",-3.0,-2.0,-1.0,30.0,PGNX
139,D,2011-01-05 16:31:28,2011-01-03,PGNX,Olson William C,"SVP, Research, Development",F - Tax,$5.68,-2351,47304,-5%,"-$13,354",-3.0,-2.0,-1.0,30.0,PGNX
140,D,2011-01-05 16:31:28,2011-01-03,PGNX,Olson William C,"SVP, Research, Development",M - OptEx,$4.83,2582,47304,+6%,"+$12,466",-3.0,-2.0,-1.0,30.0,PGNX
141,D,2011-01-05 16:29:53,2011-01-03,PGNX,Baker Mark Robert,Pres,F - Tax,$5.68,-4014,29751,-12%,"-$22,800",-3.0,-2.0,-1.0,30.0,PGNX
142,D,2011-01-05 16:29:53,2011-01-03,PGNX,Baker Mark Robert,Pres,M - OptEx,$4.83,4377,29751,+17%,"+$21,132",-3.0,-2.0,-1.0,30.0,PGNX
143,,2010-12-01 16:12:36,2010-12-01,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.90,5000,854057,+1%,"+$24,500",0.0,-2.0,9.0,59.0,PGNX
144,,2010-11-02 11:54:31,2010-11-01,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.76,5000,849057,+1%,"+$23,800",1.0,0.0,3.0,60.0,PGNX
145,D,2010-10-04 17:42:51,2010-10-01,PGNX,Olson William C,"SVP, Research, Development",F - Tax,$5.08,-6254,46871,-12%,"-$31,770",4.0,1.0,-2.0,27.0,PGNX
146,D,2010-10-04 17:42:51,2010-10-01,PGNX,Olson William C,"SVP, Research, Development",M - OptEx,$4.32,6915,46871,+17%,"+$29,859",4.0,1.0,-2.0,27.0,PGNX
147,D,2010-10-04 17:41:25,2010-10-01,PGNX,McKinney Robert A,CFO,F - Tax,$5.08,-7442,44442,-14%,"-$37,805",4.0,1.0,-2.0,27.0,PGNX
148,D,2010-10-04 17:41:25,2010-10-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.32,8229,44442,+23%,"+$35,533",4.0,1.0,-2.0,27.0,PGNX
149,D,2010-10-04 17:40:18,2010-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.08,-7945,42851,-16%,"-$40,361",4.0,1.0,-2.0,27.0,PGNX
150,D,2010-10-04 17:40:18,2010-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.32,8786,42851,+26%,"+$37,938",4.0,1.0,-2.0,27.0,PGNX
151,D,2010-10-04 17:39:03,2010-10-01,PGNX,Baker Mark Robert,Pres,F - Tax,$5.08,-15972,29186,-35%,"-$81,138",4.0,1.0,-2.0,27.0,PGNX
152,D,2010-10-04 17:39:03,2010-10-01,PGNX,Baker Mark Robert,Pres,M - OptEx,$4.32,17545,29186,+151%,"+$75,759",4.0,1.0,-2.0,27.0,PGNX
153,,2010-10-04 17:37:29,2010-10-04,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.99,5000,844057,+1%,"+$24,950",4.0,1.0,-2.0,27.0,PGNX
154,,2010-09-02 10:39:05,2010-09-01,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.10,5000,839057,+1%,"+$20,500",4.0,6.0,22.0,39.0,PGNX
155,,2010-08-02 17:13:22,2010-08-02,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.75,5000,834057,+1%,"+$23,750",5.0,5.0,-14.0,21.0,PGNX
156,,2010-07-19 15:01:32,2010-07-16,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.99,5000,829057,+1%,"+$24,950",4.0,-8.0,-3.0,32.0,PGNX
157,D,2010-07-06 14:25:55,2010-07-01,PGNX,Baker Mark Robert,Pres,F - Tax,$5.35,-4108,27395,-13%,"-$21,978",-6.0,-2.0,-11.0,0.0,PGNX
158,D,2010-07-06 14:25:55,2010-07-01,PGNX,Baker Mark Robert,Pres,M - OptEx,$4.44,4575,27395,+20%,"+$20,313",-6.0,-2.0,-11.0,0.0,PGNX
159,D,2010-07-06 14:19:03,2010-07-01,PGNX,Olson William C,"SVP, Research, Development",A - Grant,$0.00,10000,45992,+28%,+$0,-6.0,-2.0,-11.0,0.0,PGNX
160,D,2010-07-06 14:19:03,2010-07-01,PGNX,Olson William C,"SVP, Research, Development",F - Tax,$5.35,-2282,45992,-5%,"-$12,209",-6.0,-2.0,-11.0,0.0,PGNX
161,D,2010-07-06 14:19:03,2010-07-01,PGNX,Olson William C,"SVP, Research, Development",M - OptEx,$4.44,2541,45992,+6%,"+$11,282",-6.0,-2.0,-11.0,0.0,PGNX
162,D,2010-07-06 14:18:18,2010-07-01,PGNX,McKinney Robert A,CFO,A - Grant,$0.00,10000,43437,+30%,+$0,-6.0,-2.0,-11.0,0.0,PGNX
163,D,2010-07-06 14:18:18,2010-07-01,PGNX,McKinney Robert A,CFO,F - Tax,$5.35,-2402,43437,-5%,"-$12,851",-6.0,-2.0,-11.0,0.0,PGNX
164,D,2010-07-06 14:18:18,2010-07-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.44,2675,43437,+7%,"+$11,877",-6.0,-2.0,-11.0,0.0,PGNX
165,D,2010-07-06 14:17:28,2010-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",A - Grant,$0.00,10000,41792,+31%,+$0,-6.0,-2.0,-11.0,0.0,PGNX
166,D,2010-07-06 14:17:28,2010-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.35,-3223,41792,-7%,"-$17,243",-6.0,-2.0,-11.0,0.0,PGNX
167,D,2010-07-06 14:17:28,2010-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.44,3590,41792,+9%,"+$15,940",-6.0,-2.0,-11.0,0.0,PGNX
168,D,2010-07-06 14:16:33,2010-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.00,10000,47137,+27%,+$0,-6.0,-2.0,-11.0,0.0,PGNX
169,D,2010-07-06 14:16:33,2010-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$5.35,-2402,47137,-5%,"-$12,851",-6.0,-2.0,-11.0,0.0,PGNX
170,D,2010-07-06 14:16:33,2010-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$4.44,2675,47137,+6%,"+$11,877",-6.0,-2.0,-11.0,0.0,PGNX
171,,2010-06-24 10:23:25,2010-06-22,PGNX,Olson William C,"VP, Research, Development",S - Sale,$5.81,-2364,35494,-6%,"-$13,723",0.0,3.0,-19.0,-10.0,PGNX
172,,2010-06-24 10:22:39,2010-06-22,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale,$5.82,-6180,31186,-17%,"-$35,961",0.0,3.0,-19.0,-10.0,PGNX
173,,2010-06-24 10:21:43,2010-06-22,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale,$5.74,-2409,36625,-6%,"-$13,818",0.0,3.0,-19.0,-10.0,PGNX
174,,2010-06-24 10:20:32,2010-06-22,PGNX,Baker Mark Robert,Pres,S - Sale,$5.66,-2328,26689,-8%,"-$13,186",0.0,3.0,-19.0,-10.0,PGNX
175,,2010-06-21 17:19:03,2010-06-18,PGNX,McKinney Robert A,CFO,S - Sale,$6.25,-4000,32925,-11%,"-$25,000",-5.0,-6.0,-17.0,-23.0,PGNX
176,,2010-06-02 14:47:43,2010-06-01,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.99,5000,824057,+1%,"+$24,950",8.0,1.0,12.0,1.0,PGNX
177,,2010-05-21 13:29:00,2010-05-20,PGNX,Maddon Paul J,"CEO, CSO",P - Purchase,$4.93,5000,819057,+1%,"+$24,630",-5.0,9.0,28.0,-5.0,PGNX
178,,2010-04-07 09:32:52,2010-04-05,PGNX,Maddon Paul J,"CEO, CSO",A - Grant,$0.00,44723,849665,+6%,+$0,-2.0,-2.0,15.0,-9.0,PGNX
179,D,2010-04-05 16:50:09,2010-04-01,PGNX,Baker Mark Robert,Pres,F - Tax,$5.36,-3913,29017,-12%,"-$20,974",-3.0,-4.0,21.0,-10.0,PGNX
180,D,2010-04-05 16:50:09,2010-04-01,PGNX,Baker Mark Robert,Pres,M - OptEx,$4.56,4300,29017,+17%,"+$19,591",-3.0,-4.0,21.0,-10.0,PGNX
181,D,2010-04-05 16:36:33,2010-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.36,-3201,37366,-8%,"-$17,157",-3.0,-4.0,21.0,-10.0,PGNX
182,D,2010-04-05 16:36:33,2010-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.56,3518,37366,+10%,"+$16,028",-3.0,-4.0,21.0,-10.0,PGNX
183,D,2010-04-05 16:35:33,2010-04-01,PGNX,McKinney Robert A,CFO,F - Tax,$5.36,-2385,36925,-6%,"-$12,784",-3.0,-4.0,21.0,-10.0,PGNX
184,D,2010-04-05 16:35:33,2010-04-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.56,2621,36925,+8%,"+$11,941",-3.0,-4.0,21.0,-10.0,PGNX
185,D,2010-04-05 16:34:40,2010-04-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$5.36,-2266,37858,-6%,"-$12,146",-3.0,-4.0,21.0,-10.0,PGNX
186,D,2010-04-05 16:34:40,2010-04-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.56,2490,37858,+7%,"+$11,344",-3.0,-4.0,21.0,-10.0,PGNX
187,D,2010-04-05 16:32:05,2010-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$5.36,-2385,39034,-6%,"-$12,784",-3.0,-4.0,21.0,-10.0,PGNX
188,D,2010-04-05 16:32:05,2010-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$4.56,2621,39034,+7%,"+$11,941",-3.0,-4.0,21.0,-10.0,PGNX
189,D,2010-04-05 16:29:46,2010-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$5.36,-2385,39034,-6%,"-$12,784",-3.0,-4.0,21.0,-10.0,PGNX
190,D,2010-04-05 16:29:46,2010-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$4.56,2621,39034,+7%,"+$11,941",-3.0,-4.0,21.0,-10.0,PGNX
191,,2010-03-18 15:54:38,2010-03-18,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale,$5.37,-7056,36842,-16%,"-$37,891",-2.0,-2.0,4.0,-16.0,PGNX
192,,2010-03-18 15:53:33,2010-03-18,PGNX,Baker Mark Robert,Pres,S - Sale,$5.33,-2165,28423,-7%,"-$11,539",-2.0,-2.0,4.0,-16.0,PGNX
193,D,2010-01-06 15:17:09,2010-01-04,PGNX,Olson William C,"VP, Research, Development",F - Tax,$4.45,-2720,37427,-7%,"-$12,104",-2.0,1.0,3.0,24.0,PGNX
194,D,2010-01-06 15:17:09,2010-01-04,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$3.78,2989,37427,+9%,"+$11,307",-2.0,1.0,3.0,24.0,PGNX
195,D,2010-01-06 15:15:41,2010-01-04,PGNX,McKinney Robert A,CFO,F - Tax,$4.45,-2864,36482,-7%,"-$12,745",-2.0,1.0,3.0,24.0,PGNX
196,D,2010-01-06 15:15:41,2010-01-04,PGNX,McKinney Robert A,CFO,M - OptEx,$3.78,3147,36482,+9%,"+$11,905",-2.0,1.0,3.0,24.0,PGNX
197,D,2010-01-06 15:13:15,2010-01-04,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$4.45,-3843,43898,-8%,"-$17,101",-2.0,1.0,3.0,24.0,PGNX
198,D,2010-01-06 15:13:15,2010-01-04,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$3.78,4223,43898,+11%,"+$15,976",-2.0,1.0,3.0,24.0,PGNX
199,D,2010-01-06 15:12:12,2010-01-04,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$4.45,-2864,38591,-7%,"-$12,745",-2.0,1.0,3.0,24.0,PGNX
200,D,2010-01-06 15:12:12,2010-01-04,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$3.78,3147,38591,+9%,"+$11,905",-2.0,1.0,3.0,24.0,PGNX
201,D,2010-01-06 15:10:36,2010-01-04,PGNX,Baker Mark Robert,GC,F - Tax,$4.45,-4295,30588,-12%,"-$19,113",-2.0,1.0,3.0,24.0,PGNX
202,D,2010-01-06 15:10:36,2010-01-04,PGNX,Baker Mark Robert,GC,M - OptEx,$3.78,4720,30588,+18%,"+$17,856",-2.0,1.0,3.0,24.0,PGNX
203,,2009-10-19 10:58:17,2009-10-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",P - Purchase,$4.88,18500,804942,+2%,"+$90,243",4.0,-7.0,-13.0,21.0,PGNX
204,D,2009-10-05 16:05:24,2009-10-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$5.01,-2305,36910,-6%,"-$11,548",6.0,3.0,-19.0,11.0,PGNX
205,D,2009-10-05 16:05:24,2009-10-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.26,2533,36910,+7%,"+$10,788",6.0,3.0,-19.0,11.0,PGNX
206,D,2009-10-05 16:04:58,2009-10-01,PGNX,McKinney Robert A,CFO,F - Tax,$5.01,-2426,35951,-6%,"-$12,154",6.0,3.0,-19.0,11.0,PGNX
207,D,2009-10-05 16:04:58,2009-10-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.26,2666,35951,+8%,"+$11,354",6.0,3.0,-19.0,11.0,PGNX
208,D,2009-10-05 16:04:32,2009-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.01,-3256,43270,-7%,"-$16,313",6.0,3.0,-19.0,11.0,PGNX
209,D,2009-10-05 16:04:32,2009-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.26,3578,43270,+9%,"+$15,239",6.0,3.0,-19.0,11.0,PGNX
210,D,2009-10-05 16:04:04,2009-10-01,PGNX,Baker Mark Robert,GC,F - Tax,$5.01,-3639,29915,-11%,"-$18,231",6.0,3.0,-19.0,11.0,PGNX
211,D,2009-10-05 16:04:04,2009-10-01,PGNX,Baker Mark Robert,GC,M - OptEx,$4.26,3999,29915,+15%,"+$17,032",6.0,3.0,-19.0,11.0,PGNX
212,D,2009-10-05 16:03:24,2009-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$5.01,-2426,38060,-6%,"-$12,154",6.0,3.0,-19.0,11.0,PGNX
213,D,2009-10-05 16:03:24,2009-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$4.26,2666,38060,+8%,"+$11,354",6.0,3.0,-19.0,11.0,PGNX
214,D,2009-07-06 14:57:47,2009-07-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$5.33,-5880,36472,-14%,"-$31,340",1.0,2.0,14.0,-13.0,PGNX
215,D,2009-07-06 14:57:47,2009-07-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$5.33,6461,36472,+22%,"+$34,437",1.0,2.0,14.0,-13.0,PGNX
216,D,2009-07-06 14:56:57,2009-07-01,PGNX,McKinney Robert A,CFO,F - Tax,$5.33,-7041,35501,-17%,"-$37,529",1.0,2.0,14.0,-13.0,PGNX
217,D,2009-07-06 14:56:57,2009-07-01,PGNX,McKinney Robert A,CFO,M - OptEx,$5.33,7738,35501,+28%,"+$41,244",1.0,2.0,14.0,-13.0,PGNX
218,D,2009-07-06 14:55:59,2009-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$5.33,-7471,42738,-15%,"-$39,820",1.0,2.0,14.0,-13.0,PGNX
219,D,2009-07-06 14:55:59,2009-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.33,8210,42738,+24%,"+$43,759",1.0,2.0,14.0,-13.0,PGNX
220,D,2009-07-06 14:54:25,2009-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$5.33,-7041,37610,-16%,"-$37,529",1.0,2.0,14.0,-13.0,PGNX
221,D,2009-07-06 14:54:25,2009-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$5.33,7738,37610,+26%,"+$41,244",1.0,2.0,14.0,-13.0,PGNX
222,D,2009-07-06 14:53:34,2009-07-01,PGNX,Baker Mark Robert,GC,F - Tax,$5.33,-12018,29345,-29%,"-$64,056",1.0,2.0,14.0,-13.0,PGNX
223,D,2009-07-06 14:53:34,2009-07-01,PGNX,Baker Mark Robert,GC,M - OptEx,$5.33,13207,29345,+82%,"+$70,393",1.0,2.0,14.0,-13.0,PGNX
224,,2009-06-24 17:17:53,2009-06-23,PGNX,Olson William C,"VP, Research, Development",S - Sale,$4.73,-2500,35677,-7%,"-$11,815",2.0,10.0,12.0,-7.0,PGNX
225,,2009-06-24 17:15:03,2009-06-23,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale,$4.73,-2000,36699,-5%,"-$9,468",2.0,10.0,12.0,-7.0,PGNX
226,,2009-06-22 15:06:38,2009-06-19,PGNX,McKinney Robert A,CFO,S - Sale,$5.25,-5000,34590,-13%,"-$26,265",-11.0,1.0,4.0,-19.0,PGNX
227,,2009-04-22 15:13:11,2009-04-21,PGNX,Williams Nicole,Dir,A - Grant,$5.40,5000,5000,New,"+$26,984",0.0,4.0,-3.0,-9.0,PGNX
228,D,2009-04-03 16:36:13,2009-04-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$6.65,-1832,38177,-5%,"-$12,183",-7.0,-6.0,-23.0,-26.0,PGNX
229,D,2009-04-03 16:36:13,2009-04-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$5.65,2014,38177,+6%,"+$11,379",-7.0,-6.0,-23.0,-26.0,PGNX
230,D,2009-04-03 16:35:14,2009-04-01,PGNX,McKinney Robert A,CFO,F - Tax,$6.65,-1929,39590,-5%,"-$12,828",-7.0,-6.0,-23.0,-26.0,PGNX
231,D,2009-04-03 16:35:14,2009-04-01,PGNX,McKinney Robert A,CFO,M - OptEx,$5.65,2120,39590,+6%,"+$11,978",-7.0,-6.0,-23.0,-26.0,PGNX
232,D,2009-04-03 16:34:39,2009-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$6.65,-2588,41785,-6%,"-$17,210",-7.0,-6.0,-23.0,-26.0,PGNX
233,D,2009-04-03 16:34:39,2009-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.65,2845,41785,+7%,"+$16,074",-7.0,-6.0,-23.0,-26.0,PGNX
234,D,2009-04-03 16:34:05,2009-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$6.65,-1929,38699,-5%,"-$12,828",-7.0,-6.0,-23.0,-26.0,PGNX
235,D,2009-04-03 16:34:05,2009-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$5.65,2120,38699,+6%,"+$11,978",-7.0,-6.0,-23.0,-26.0,PGNX
236,D,2009-04-03 16:32:44,2009-04-01,PGNX,Baker Mark Robert,GC,F - Tax,$6.65,-2893,27942,-9%,"-$19,238",-7.0,-6.0,-23.0,-26.0,PGNX
237,D,2009-04-03 16:32:44,2009-04-01,PGNX,Baker Mark Robert,GC,M - OptEx,$5.65,3180,27942,+13%,"+$17,967",-7.0,-6.0,-23.0,-26.0,PGNX
238,,2009-03-23 16:50:24,2009-03-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,66294,786442,+9%,+$0,-5.0,12.0,-17.0,-12.0,PGNX
239,D,2009-01-06 15:37:04,2009-01-02,PGNX,Olson William C,"VP, Research, Development",F - Tax,$10.74,-1171,37827,-3%,"-$12,577",-6.0,-9.0,-29.0,-52.0,PGNX
240,D,2009-01-06 15:37:04,2009-01-02,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$9.13,1287,37827,+4%,"+$11,750",-6.0,-9.0,-29.0,-52.0,PGNX
241,D,2009-01-06 15:36:33,2009-01-02,PGNX,McKinney Robert A,CFO,F - Tax,$10.74,-1233,39231,-3%,"-$13,242",-6.0,-9.0,-29.0,-52.0,PGNX
242,D,2009-01-06 15:36:33,2009-01-02,PGNX,McKinney Robert A,CFO,M - OptEx,$9.13,1355,39231,+4%,"+$12,371",-6.0,-9.0,-29.0,-52.0,PGNX
243,D,2009-01-06 15:36:11,2009-01-02,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$10.74,-1654,41360,-4%,"-$17,764",-6.0,-9.0,-29.0,-52.0,PGNX
244,D,2009-01-06 15:36:11,2009-01-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$9.13,1819,41360,+5%,"+$16,607",-6.0,-9.0,-29.0,-52.0,PGNX
245,D,2009-01-06 15:35:21,2009-01-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$10.74,-1233,38340,-3%,"-$13,242",-6.0,-9.0,-29.0,-52.0,PGNX
246,D,2009-01-06 15:35:21,2009-01-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$9.13,1355,38340,+4%,"+$12,371",-6.0,-9.0,-29.0,-52.0,PGNX
247,D,2009-01-06 15:34:43,2009-01-02,PGNX,Baker Mark Robert,GC,F - Tax,$10.74,-1849,27487,-6%,"-$19,858",-6.0,-9.0,-29.0,-52.0,PGNX
248,D,2009-01-06 15:34:43,2009-01-02,PGNX,Baker Mark Robert,GC,M - OptEx,$9.13,2033,27487,+8%,"+$18,561",-6.0,-9.0,-29.0,-52.0,PGNX
249,M,2008-10-24 16:34:22,2008-10-22,PGNX,Jacobson Paul F,Dir,S - Sale,$9.24,-62500,125600,-33%,"-$577,626",-9.0,6.0,-13.0,-34.0,PGNX
250,D,2008-10-03 12:10:21,2008-10-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$13.93,-1011,37604,-3%,"-$14,083",-5.0,-17.0,-26.0,-49.0,PGNX
251,D,2008-10-03 12:10:21,2008-10-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$6.53,1484,37604,+4%,"+$9,691",-5.0,-17.0,-26.0,-49.0,PGNX
252,D,2008-10-03 12:09:22,2008-10-01,PGNX,McKinney Robert A,CFO,F - Tax,$13.93,-1239,39002,-3%,"-$17,259",-5.0,-17.0,-26.0,-49.0,PGNX
253,D,2008-10-03 12:09:22,2008-10-01,PGNX,McKinney Robert A,CFO,M - OptEx,$6.53,1819,39002,+5%,"+$11,878",-5.0,-17.0,-26.0,-49.0,PGNX
254,D,2008-10-03 12:08:29,2008-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$13.93,-1663,41088,-4%,"-$23,166",-5.0,-17.0,-26.0,-49.0,PGNX
255,D,2008-10-03 12:08:29,2008-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$6.53,2441,41088,+6%,"+$15,940",-5.0,-17.0,-26.0,-49.0,PGNX
256,D,2008-10-03 12:06:29,2008-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$13.93,-2987,38111,-7%,"-$41,609",-5.0,-17.0,-26.0,-49.0,PGNX
257,D,2008-10-03 12:06:29,2008-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$6.53,4384,38111,+13%,"+$28,628",-5.0,-17.0,-26.0,-49.0,PGNX
258,D,2008-10-03 12:04:36,2008-10-01,PGNX,Baker Mark Robert,GC,F - Tax,$13.93,-1631,27196,-6%,"-$22,720",-5.0,-17.0,-26.0,-49.0,PGNX
259,D,2008-10-03 12:04:36,2008-10-01,PGNX,Baker Mark Robert,GC,M - OptEx,$6.53,2393,27196,+10%,"+$15,626",-5.0,-17.0,-26.0,-49.0,PGNX
260,D,2008-09-04 10:24:14,2008-09-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,39801,+3%,"+$12,290",-6.0,-12.0,-10.0,-61.0,PGNX
261,D,2008-09-04 10:24:14,2008-09-03,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$15.00,-1000,39801,-2%,"-$15,000",-6.0,-12.0,-10.0,-61.0,PGNX
262,D,2008-08-29 10:53:10,2008-08-28,PGNX,Briner Kurt W,Dir,M - OptEx,$9.63,50000,53000,>999%,"+$481,250",0.0,3.0,-2.0,-56.0,PGNX
263,D,2008-08-05 10:07:41,2008-08-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,39801,+3%,"+$12,290",1.0,-11.0,-9.0,-58.0,PGNX
264,D,2008-08-05 10:07:41,2008-08-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$16.47,-1000,39801,-2%,"-$16,465",1.0,-11.0,-9.0,-58.0,PGNX
265,D,2008-07-17 14:07:46,2008-07-15,PGNX,Jacobson Paul F,Dir,M - OptEx,$6.88,10000,188000,+6%,"+$68,820",4.0,7.0,-15.0,-42.0,PGNX
266,D,2008-07-17 14:07:46,2008-07-15,PGNX,Jacobson Paul F,Dir,S - Sale+OE,$16.04,-10000,188000,-5%,"-$160,350",4.0,7.0,-15.0,-42.0,PGNX
267,D,2008-07-03 13:35:24,2008-07-01,PGNX,Olson William C,"VP, Research, Development",A - Grant,$0.00,6667,36622,+22%,+$0,-2.0,10.0,11.0,-32.0,PGNX
268,D,2008-07-03 13:35:24,2008-07-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$16.05,-2089,36622,-5%,"-$33,528",-2.0,10.0,11.0,-32.0,PGNX
269,D,2008-07-03 13:35:24,2008-07-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$13.64,2296,36622,+7%,"+$31,317",-2.0,10.0,11.0,-32.0,PGNX
270,D,2008-07-03 13:33:42,2008-07-01,PGNX,McKinney Robert A,CFO,A - Grant,$0.00,8333,37913,+28%,+$0,-2.0,10.0,11.0,-32.0,PGNX
271,D,2008-07-03 13:33:42,2008-07-01,PGNX,McKinney Robert A,CFO,F - Tax,$16.05,-2658,37913,-7%,"-$42,661",-2.0,10.0,11.0,-32.0,PGNX
272,D,2008-07-03 13:33:42,2008-07-01,PGNX,McKinney Robert A,CFO,M - OptEx,$13.64,2921,37913,+8%,"+$39,842",-2.0,10.0,11.0,-32.0,PGNX
273,D,2008-07-03 13:31:51,2008-07-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,25000,720148,+4%,+$0,-2.0,10.0,11.0,-32.0,PGNX
274,D,2008-07-03 13:29:57,2008-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",A - Grant,$0.00,6667,39801,+20%,+$0,-2.0,10.0,11.0,-32.0,PGNX
275,D,2008-07-03 13:29:57,2008-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$16.05,-2764,39801,-6%,"-$44,362",-2.0,10.0,11.0,-32.0,PGNX
276,D,2008-07-03 13:29:57,2008-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$13.31,4037,39801,+11%,"+$53,715",-2.0,10.0,11.0,-32.0,PGNX
277,D,2008-07-03 13:29:57,2008-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$15.59,-1000,39801,-2%,"-$15,592",-2.0,10.0,11.0,-32.0,PGNX
278,D,2008-07-03 13:28:02,2008-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.00,6667,36205,+23%,+$0,-2.0,10.0,11.0,-32.0,PGNX
279,D,2008-07-03 13:28:02,2008-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$16.05,-2658,36205,-7%,"-$42,661",-2.0,10.0,11.0,-32.0,PGNX
280,D,2008-07-03 13:28:02,2008-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$13.64,2921,36205,+9%,"+$39,842",-2.0,10.0,11.0,-32.0,PGNX
281,D,2008-07-03 13:18:47,2008-07-01,PGNX,Baker Mark Robert,GC,F - Tax,$16.05,-4427,25925,-15%,"-$71,053",-2.0,10.0,11.0,-32.0,PGNX
282,D,2008-07-03 13:18:47,2008-07-01,PGNX,Baker Mark Robert,GC,M - OptEx,$13.64,4865,25925,+23%,"+$66,359",-2.0,10.0,11.0,-32.0,PGNX
283,,2008-06-24 14:52:04,2008-06-23,PGNX,Olson William C,"VP, Research, Development",D - Sale to issuer,$17.01,-3500,29678,-11%,"-$59,546",-4.0,-4.0,3.0,-46.0,PGNX
284,,2008-06-24 14:48:56,2008-06-23,PGNX,Israel Robert J,"SVP, Medical Affairs",D - Sale to issuer,$17.02,-3500,32791,-10%,"-$59,553",-4.0,-4.0,3.0,-46.0,PGNX
285,,2008-06-24 14:46:15,2008-06-23,PGNX,Boyd Thomas A,"SVP, Product Dev.",D - Sale to issuer,$17.01,-2700,29205,-8%,"-$45,914",-4.0,-4.0,3.0,-46.0,PGNX
286,,2008-06-24 14:40:19,2008-06-20,PGNX,McKinney Robert A,CFO,D - Sale to issuer,$17.15,-4665,29247,-14%,"-$79,986",-4.0,-4.0,3.0,-46.0,PGNX
287,D,2008-06-02 16:26:25,2008-06-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,36291,+3%,"+$12,290",-1.0,2.0,-2.0,-40.0,PGNX
288,D,2008-06-02 16:26:25,2008-06-02,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$16.40,-1000,36291,-3%,"-$16,397",-1.0,2.0,-2.0,-40.0,PGNX
289,D,2008-05-28 14:14:06,2008-05-27,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,36291,+3%,"+$12,290",0.0,4.0,9.0,-50.0,PGNX
290,D,2008-05-28 14:14:06,2008-05-27,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$15.00,-1000,36291,-3%,"-$15,000",0.0,4.0,9.0,-50.0,PGNX
291,D,2008-05-16 14:23:41,2008-05-14,PGNX,Dalton Mark F,Dir,M - OptEx,$5.36,7500,95000,+9%,"+$40,225",0.0,17.0,43.0,-16.0,PGNX
292,D,2008-04-28 15:19:38,2008-04-25,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,36291,+3%,"+$12,290",5.0,0.0,15.0,-32.0,PGNX
293,D,2008-04-28 15:19:38,2008-04-25,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$15.00,-1000,36291,-3%,"-$15,000",5.0,0.0,15.0,-32.0,PGNX
294,D,2008-04-03 17:09:57,2008-04-01,PGNX,Kremer Alton B,"VP, Clinical Research",D - Sale to issuer,$0.00,-5000,25302,-17%,-$0,2.0,2.0,84.0,79.0,PGNX
295,D,2008-04-03 17:09:57,2008-04-01,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$7.67,-2869,25302,-10%,"-$22,005",2.0,2.0,84.0,79.0,PGNX
296,D,2008-04-03 17:09:57,2008-04-01,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$6.52,3153,25302,+14%,"+$20,558",2.0,2.0,84.0,79.0,PGNX
297,D,2008-04-03 15:57:25,2008-04-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$7.67,-1435,33178,-4%,"-$11,006",0.0,2.0,84.0,79.0,PGNX
298,D,2008-04-03 15:57:25,2008-04-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$6.52,1576,33178,+5%,"+$10,276",0.0,2.0,84.0,79.0,PGNX
299,D,2008-04-03 15:52:49,2008-04-01,PGNX,McKinney Robert A,CFO,F - Tax,$7.67,-1742,33912,-5%,"-$13,361",0.0,2.0,84.0,79.0,PGNX
300,D,2008-04-03 15:52:49,2008-04-01,PGNX,McKinney Robert A,CFO,M - OptEx,$6.52,1914,33912,+6%,"+$12,479",0.0,2.0,84.0,79.0,PGNX
301,D,2008-04-03 15:45:16,2008-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$7.67,-2459,36291,-6%,"-$18,861",0.0,2.0,84.0,79.0,PGNX
302,D,2008-04-03 15:45:16,2008-04-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$6.52,2702,36291,+8%,"+$17,617",0.0,2.0,84.0,79.0,PGNX
303,D,2008-04-03 15:40:59,2008-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",D - Sale to issuer,$0.00,-5000,31905,-14%,-$0,0.0,2.0,84.0,79.0,PGNX
304,D,2008-04-03 15:40:59,2008-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$7.67,-1742,31905,-5%,"-$13,361",0.0,2.0,84.0,79.0,PGNX
305,D,2008-04-03 15:40:59,2008-04-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$6.52,1914,31905,+6%,"+$12,479",0.0,2.0,84.0,79.0,PGNX
306,D,2008-04-03 15:36:48,2008-04-01,PGNX,Baker Mark Robert,GC,F - Tax,$7.67,-2305,25417,-8%,"-$17,679",0.0,2.0,84.0,79.0,PGNX
307,D,2008-04-03 15:36:48,2008-04-01,PGNX,Baker Mark Robert,GC,M - OptEx,$6.52,2533,25417,+11%,"+$16,515",0.0,2.0,84.0,79.0,PGNX
308,D,2008-04-01 11:16:23,2008-03-28,PGNX,Scheinberg David A,Dir,M - OptEx,$4.68,7500,46185,+19%,"+$35,093",17.0,19.0,105.0,117.0,PGNX
309,D,2008-03-04 15:49:41,2008-03-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,35879,+3%,"+$12,290",-4.0,-17.0,-53.0,-12.0,PGNX
310,D,2008-03-04 15:49:41,2008-03-03,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$15.30,-1000,35879,-3%,"-$15,300",-4.0,-17.0,-53.0,-12.0,PGNX
311,D,2008-02-04 14:53:35,2008-02-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,35879,+3%,"+$12,290",-1.0,-7.0,-12.0,-2.0,PGNX
312,D,2008-02-04 14:53:35,2008-02-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$16.44,-1000,35879,-3%,"-$16,440",-1.0,-7.0,-12.0,-2.0,PGNX
313,D,2008-01-04 15:39:33,2008-01-02,PGNX,Olson William C,"VP, Research, Development",F - Tax,$18.03,-519,32868,-2%,"-$9,358",-7.0,4.0,-3.0,-15.0,PGNX
314,D,2008-01-04 15:39:33,2008-01-02,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$15.33,570,32868,+2%,"+$8,738",-7.0,4.0,-3.0,-15.0,PGNX
315,D,2008-01-04 15:39:04,2008-01-02,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$18.03,-889,35879,-2%,"-$16,029",-7.0,4.0,-3.0,-15.0,PGNX
316,D,2008-01-04 15:39:04,2008-01-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$13.79,1977,35879,+6%,"+$27,267",-7.0,4.0,-3.0,-15.0,PGNX
317,D,2008-01-04 15:39:04,2008-01-02,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$18.12,-1000,35879,-3%,"-$18,120",-7.0,4.0,-3.0,-15.0,PGNX
318,D,2008-01-04 15:38:30,2008-01-02,PGNX,McKinney Robert A,CFO,F - Tax,$18.03,-630,33571,-2%,"-$11,359",-7.0,4.0,-3.0,-15.0,PGNX
319,D,2008-01-04 15:38:30,2008-01-02,PGNX,McKinney Robert A,CFO,M - OptEx,$15.33,692,33571,+2%,"+$10,608",-7.0,4.0,-3.0,-15.0,PGNX
320,D,2008-01-04 15:37:47,2008-01-02,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$18.03,-1036,29849,-3%,"-$18,679",-7.0,4.0,-3.0,-15.0,PGNX
321,D,2008-01-04 15:37:47,2008-01-02,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$15.36,1139,29849,+4%,"+$17,495",-7.0,4.0,-3.0,-15.0,PGNX
322,D,2008-01-04 15:36:32,2008-01-02,PGNX,Baker Mark Robert,GC,F - Tax,$18.03,-834,25020,-3%,"-$15,037",-7.0,4.0,-3.0,-15.0,PGNX
323,D,2008-01-04 15:36:32,2008-01-02,PGNX,Baker Mark Robert,GC,M - OptEx,$15.33,916,25020,+4%,"+$14,042",-7.0,4.0,-3.0,-15.0,PGNX
324,D,2008-01-04 15:27:39,2008-01-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$18.03,-630,36564,-2%,"-$11,359",-7.0,4.0,-3.0,-15.0,PGNX
325,D,2008-01-04 15:27:39,2008-01-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$15.33,692,36564,+2%,"+$10,608",-7.0,4.0,-3.0,-15.0,PGNX
326,D,2007-12-10 14:27:33,2007-12-06,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$13.75,1000,35730,+3%,"+$13,750",1.0,-7.0,-17.0,-24.0,PGNX
327,D,2007-12-10 14:27:33,2007-12-06,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$20.00,-1000,35730,-3%,"-$20,000",1.0,-7.0,-17.0,-24.0,PGNX
328,D,2007-12-05 17:28:57,2007-12-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.00,4000,32756,+14%,"+$16,000",9.0,11.0,-15.0,-9.0,PGNX
329,D,2007-12-05 17:28:57,2007-12-03,PGNX,Olson William C,"VP, Research, Development",S - Sale+OE,$19.03,-4000,32756,-11%,"-$76,112",9.0,11.0,-15.0,-9.0,PGNX
330,D,2007-12-05 16:29:54,2007-12-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$12.29,1000,35730,+3%,"+$12,290",9.0,11.0,-15.0,-9.0,PGNX
331,D,2007-12-05 16:29:54,2007-12-03,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$19.24,-1000,35730,-3%,"-$19,239",9.0,11.0,-15.0,-9.0,PGNX
332,AD,2007-10-25 12:41:41,2007-10-03,PGNX,Scheinberg David A,Dir,A - Grant,$0.00,6501,38682,+20%,+$0,-1.0,0.0,-15.0,-42.0,PGNX
333,D,2007-10-17 10:54:18,2007-10-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,15000,695148,+2%,"+$79,950",0.0,1.0,-8.0,-71.0,PGNX
334,D,2007-10-17 10:54:18,2007-10-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.49,-15000,695148,-2%,"-$352,380",0.0,1.0,-8.0,-71.0,PGNX
335,D,2007-10-04 16:51:36,2007-10-03,PGNX,Scheinberg David A,Dir,A - Grant,$0.00,6504,38685,+20%,+$0,1.0,3.0,3.0,-66.0,PGNX
336,D,2007-10-03 17:13:27,2007-10-01,PGNX,Olson William C,"VP, Research, Development",F - Tax,$22.39,-424,32756,-1%,"-$9,493",1.0,4.0,5.0,-66.0,PGNX
337,D,2007-10-03 17:13:27,2007-10-01,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$19.03,466,32756,+1%,"+$8,868",1.0,4.0,5.0,-66.0,PGNX
338,D,2007-10-03 17:09:19,2007-10-01,PGNX,McKinney Robert A,CFO,F - Tax,$22.39,-514,33448,-2%,"-$11,508",1.0,4.0,5.0,-66.0,PGNX
339,D,2007-10-03 17:09:19,2007-10-01,PGNX,McKinney Robert A,CFO,M - OptEx,$19.03,565,33448,+2%,"+$10,752",1.0,4.0,5.0,-66.0,PGNX
340,D,2007-10-03 17:05:12,2007-10-01,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$22.39,-2119,29685,-7%,"-$47,444",1.0,4.0,5.0,-66.0,PGNX
341,D,2007-10-03 17:05:12,2007-10-01,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$19.03,2328,29685,+9%,"+$44,302",1.0,4.0,5.0,-66.0,PGNX
342,D,2007-10-03 16:59:55,2007-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$22.39,-726,35730,-2%,"-$16,255",1.0,4.0,5.0,-66.0,PGNX
343,D,2007-10-03 16:59:55,2007-10-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$19.03,798,35730,+2%,"+$15,186",1.0,4.0,5.0,-66.0,PGNX
344,D,2007-10-03 16:55:55,2007-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$22.39,-1847,36441,-5%,"-$41,354",1.0,4.0,5.0,-66.0,PGNX
345,D,2007-10-03 16:55:55,2007-10-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$19.03,2029,36441,+6%,"+$38,612",1.0,4.0,5.0,-66.0,PGNX
346,D,2007-10-03 16:51:27,2007-10-01,PGNX,Baker Mark Robert,GC,F - Tax,$22.39,-681,24877,-3%,"-$15,248",1.0,4.0,5.0,-66.0,PGNX
347,D,2007-10-03 16:51:27,2007-10-01,PGNX,Baker Mark Robert,GC,M - OptEx,$19.03,748,24877,+3%,"+$14,234",1.0,4.0,5.0,-66.0,PGNX
348,D,2007-10-03 16:36:24,2007-10-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$22.39,-1816,695148,0%,"-$40,660",1.0,4.0,5.0,-66.0,PGNX
349,D,2007-10-03 16:36:24,2007-10-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.28,13995,695148,+2%,"+$101,925",1.0,4.0,5.0,-66.0,PGNX
350,D,2007-10-03 16:36:24,2007-10-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$22.03,-12000,695148,-2%,"-$264,312",1.0,4.0,5.0,-66.0,PGNX
351,D,2007-09-19 10:18:10,2007-09-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,694969,+2%,"+$63,960",1.0,-6.0,-2.0,-79.0,PGNX
352,D,2007-09-19 10:18:10,2007-09-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.39,-12000,694969,-2%,"-$280,728",1.0,-6.0,-2.0,-79.0,PGNX
353,D,2007-09-06 10:55:07,2007-09-04,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,694969,+2%,"+$63,960",-1.0,-5.0,-13.0,-44.0,PGNX
354,D,2007-09-06 10:55:07,2007-09-04,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.77,-12000,694969,-2%,"-$285,180",-1.0,-5.0,-13.0,-44.0,PGNX
355,D,2007-08-16 16:31:00,2007-08-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,36209,+6%,"+$32,598",0.0,-1.0,0.0,-33.0,PGNX
356,D,2007-08-16 16:31:00,2007-08-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$22.90,-2000,36209,-5%,"-$45,799",0.0,-1.0,0.0,-33.0,PGNX
357,D,2007-08-16 16:28:22,2007-08-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,694969,+2%,"+$63,960",0.0,-1.0,0.0,-33.0,PGNX
358,D,2007-08-16 16:28:22,2007-08-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.16,-12000,694969,-2%,"-$277,860",0.0,-1.0,0.0,-33.0,PGNX
359,D,2007-08-02 18:23:36,2007-08-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,694969,+2%,"+$63,960",0.0,15.0,8.0,-22.0,PGNX
360,D,2007-08-02 18:23:36,2007-08-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.23,-12000,694969,-2%,"-$254,784",0.0,15.0,8.0,-22.0,PGNX
361,D,2007-07-18 15:40:14,2007-07-16,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,36209,+6%,"+$32,598",1.0,7.0,9.0,-23.0,PGNX
362,D,2007-07-18 15:40:14,2007-07-16,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$21.58,-2000,36209,-5%,"-$43,169",1.0,7.0,9.0,-23.0,PGNX
363,D,2007-07-18 15:37:41,2007-07-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,694969,+2%,"+$63,960",1.0,7.0,9.0,-23.0,PGNX
364,D,2007-07-18 15:37:41,2007-07-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.46,-12000,694969,-2%,"-$257,472",1.0,7.0,9.0,-23.0,PGNX
365,AD,2007-07-06 12:44:37,2007-07-02,PGNX,McKinney Robert A,CFO,A - Grant,$0.00,13333,33347,+67%,+$0,2.0,1.0,-3.0,-19.0,PGNX
366,AD,2007-07-06 12:44:37,2007-07-02,PGNX,McKinney Robert A,CFO,F - Tax,$22.01,-1737,33347,-5%,"-$38,231",2.0,1.0,-3.0,-19.0,PGNX
367,AD,2007-07-06 12:44:37,2007-07-02,PGNX,McKinney Robert A,CFO,M - OptEx,$18.71,1909,33347,+6%,"+$35,717",2.0,1.0,-3.0,-19.0,PGNX
368,D,2007-07-05 17:30:36,2007-07-02,PGNX,Olson William C,"VP, Research, Development",A - Grant,$0.00,9333,32664,+40%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
369,D,2007-07-05 17:30:36,2007-07-02,PGNX,Olson William C,"VP, Research, Development",F - Tax,$22.01,-1407,32664,-4%,"-$30,968",2.0,-3.0,-2.0,-16.0,PGNX
370,D,2007-07-05 17:30:36,2007-07-02,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$18.71,1546,32664,+5%,"+$28,926",2.0,-3.0,-2.0,-16.0,PGNX
371,D,2007-07-05 17:25:05,2007-07-02,PGNX,Kremer Alton B,"VP, Clinical Research",A - Grant,$0.00,13333,29426,+83%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
372,D,2007-07-05 17:25:05,2007-07-02,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$22.01,-775,29426,-3%,"-$17,058",2.0,-3.0,-2.0,-16.0,PGNX
373,D,2007-07-05 17:25:05,2007-07-02,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$18.71,852,29426,+3%,"+$15,941",2.0,-3.0,-2.0,-16.0,PGNX
374,D,2007-07-05 17:20:22,2007-07-02,PGNX,Israel Robert J,"SVP, Medical Affairs",A - Grant,$0.00,9333,35608,+36%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
375,D,2007-07-05 17:20:22,2007-07-02,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$22.01,-1962,35608,-5%,"-$43,184",2.0,-3.0,-2.0,-16.0,PGNX
376,D,2007-07-05 17:20:22,2007-07-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$18.71,2156,35608,+6%,"+$40,339",2.0,-3.0,-2.0,-16.0,PGNX
377,D,2007-07-05 17:13:46,2007-07-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.00,9333,36209,+35%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
378,D,2007-07-05 17:13:46,2007-07-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$22.01,-496,36209,-1%,"-$10,917",2.0,-3.0,-2.0,-16.0,PGNX
379,D,2007-07-05 17:13:46,2007-07-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$18.71,545,36209,+2%,"+$10,197",2.0,-3.0,-2.0,-16.0,PGNX
380,D,2007-07-05 17:03:34,2007-07-02,PGNX,McKinney Robert A,CFO,A - Grant,$0.00,13333,33124,+67%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
381,D,2007-07-05 16:54:41,2007-07-02,PGNX,Baker Mark Robert,GC,A - Grant,$0.00,13333,24760,+117%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
382,D,2007-07-05 16:54:41,2007-07-02,PGNX,Baker Mark Robert,GC,F - Tax,$22.01,-3140,24760,-11%,"-$69,111",2.0,-3.0,-2.0,-16.0,PGNX
383,D,2007-07-05 16:54:41,2007-07-02,PGNX,Baker Mark Robert,GC,M - OptEx,$18.71,3451,24760,+16%,"+$64,568",2.0,-3.0,-2.0,-16.0,PGNX
384,D,2007-07-05 16:21:59,2007-07-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,37500,694969,+6%,+$0,2.0,-3.0,-2.0,-16.0,PGNX
385,D,2007-07-05 16:21:59,2007-07-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$22.01,-1807,694969,0%,"-$39,772",2.0,-3.0,-2.0,-16.0,PGNX
386,D,2007-07-05 16:21:59,2007-07-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.23,13986,694969,+2%,"+$101,118",2.0,-3.0,-2.0,-16.0,PGNX
387,D,2007-07-05 16:21:59,2007-07-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.68,-12000,694969,-2%,"-$260,112",2.0,-3.0,-2.0,-16.0,PGNX
388,,2007-06-26 15:46:46,2007-06-21,PGNX,Kremer Alton B,"VP, Clinical Research",D - Sale to issuer,$22.59,-2500,15965,-14%,"-$56,466",0.0,0.0,0.0,-15.0,PGNX
389,,2007-06-25 15:38:50,2007-06-21,PGNX,Israel Robert J,"SVP, Medical Affairs",D - Sale to issuer,$22.46,-900,26030,-3%,"-$20,214",-2.0,-4.0,1.0,-16.0,PGNX
390,,2007-06-25 15:36:45,2007-06-21,PGNX,Boyd Thomas A,"SVP, Product Dev.",D - Sale to issuer,$22.65,-2150,26776,-7%,"-$48,689",-2.0,-4.0,1.0,-16.0,PGNX
391,,2007-06-21 14:54:36,2007-06-20,PGNX,McKinney Robert A,CFO,D - Sale to issuer,$22.83,-3000,19791,-13%,"-$68,490",0.0,-1.0,6.0,-15.0,PGNX
392,,2007-06-21 14:50:51,2007-06-20,PGNX,Olson William C,"VP, Research, Development",D - Sale to issuer,$22.83,-1000,23141,-4%,"-$22,829",0.0,-1.0,6.0,-15.0,PGNX
393,D,2007-06-18 16:33:35,2007-06-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,28926,+7%,"+$32,598",0.0,-2.0,-7.0,-8.0,PGNX
394,D,2007-06-18 16:33:35,2007-06-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$22.02,-2000,28926,-6%,"-$44,043",0.0,-2.0,-7.0,-8.0,PGNX
395,D,2007-06-04 17:01:05,2007-06-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657290,+2%,"+$63,960",-2.0,-3.0,-4.0,-13.0,PGNX
396,D,2007-06-04 17:01:05,2007-06-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.75,-12000,657290,-2%,"-$261,012",-2.0,-3.0,-4.0,-13.0,PGNX
397,D,2007-05-16 17:29:51,2007-05-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,28926,+7%,"+$32,598",-2.0,2.0,-1.0,0.0,PGNX
398,D,2007-05-16 17:29:51,2007-05-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$21.91,-2000,28926,-6%,"-$43,812",-2.0,2.0,-1.0,0.0,PGNX
399,D,2007-05-16 17:26:39,2007-05-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657290,+2%,"+$63,960",-2.0,2.0,-1.0,0.0,PGNX
400,D,2007-05-16 17:26:39,2007-05-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.90,-12000,657290,-2%,"-$262,800",-2.0,2.0,-1.0,0.0,PGNX
401,D,2007-05-03 15:38:47,2007-05-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657290,+2%,"+$63,960",-3.0,-7.0,-10.0,-8.0,PGNX
402,D,2007-05-03 15:38:47,2007-05-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$25.61,-12000,657290,-2%,"-$307,356",-3.0,-7.0,-10.0,-8.0,PGNX
403,,2007-04-24 14:27:00,2007-03-30,PGNX,Kremer Alton B,"VP, Clinical Research",D - Sale to issuer,$0.00,-5000,18187,-22%,-$0,-3.0,-10.0,-17.0,-15.0,PGNX
404,D,2007-04-18 13:23:35,2007-03-30,PGNX,Boyd Thomas A,"SVP, Product Dev.",D - Sale to issuer,$0.00,-5000,28926,-15%,-$0,-3.0,-2.0,-17.0,-10.0,PGNX
405,D,2007-04-18 13:23:35,2007-04-16,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,28926,+7%,"+$32,598",-3.0,-2.0,-17.0,-10.0,PGNX
406,D,2007-04-18 13:23:35,2007-04-16,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$26.88,-2000,28926,-6%,"-$53,751",-3.0,-2.0,-17.0,-10.0,PGNX
407,D,2007-04-17 18:10:49,2007-04-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657290,+2%,"+$63,960",-3.0,1.0,-18.0,-12.0,PGNX
408,D,2007-04-17 18:10:49,2007-04-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$26.80,-12000,657290,-2%,"-$321,588",-3.0,1.0,-18.0,-12.0,PGNX
409,D,2007-04-04 15:54:28,2007-04-02,PGNX,Olson William C,"VP, Research, Development",F - Tax,$24.10,-355,24141,-1%,"-$8,556",-2.0,3.0,-3.0,-11.0,PGNX
410,D,2007-04-04 15:54:28,2007-04-02,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$20.13,394,24141,+2%,"+$7,931",-2.0,3.0,-3.0,-11.0,PGNX
411,D,2007-04-04 15:51:48,2007-04-02,PGNX,McKinney Robert A,CFO,F - Tax,$24.10,-420,22791,-2%,"-$10,122",-2.0,3.0,-3.0,-11.0,PGNX
412,D,2007-04-04 15:51:48,2007-04-02,PGNX,McKinney Robert A,CFO,M - OptEx,$20.13,466,22791,+2%,"+$9,381",-2.0,3.0,-3.0,-11.0,PGNX
413,D,2007-04-04 15:48:41,2007-04-02,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$24.10,-2071,23465,-8%,"-$49,911",-2.0,3.0,-3.0,-11.0,PGNX
414,D,2007-04-04 15:48:41,2007-04-02,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$20.13,2298,23465,+11%,"+$46,259",-2.0,3.0,-3.0,-11.0,PGNX
415,D,2007-04-04 15:45:53,2007-04-02,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$24.10,-630,26930,-2%,"-$15,183",-2.0,3.0,-3.0,-11.0,PGNX
416,D,2007-04-04 15:45:53,2007-04-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$20.13,699,26930,+3%,"+$14,071",-2.0,3.0,-3.0,-11.0,PGNX
417,D,2007-04-04 15:42:35,2007-04-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$24.10,-1819,33926,-5%,"-$43,838",-2.0,3.0,-3.0,-11.0,PGNX
418,D,2007-04-04 15:42:35,2007-04-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$20.13,2018,33926,+6%,"+$40,622",-2.0,3.0,-3.0,-11.0,PGNX
419,D,2007-04-04 15:22:34,2007-04-02,PGNX,Baker Mark Robert,GC,F - Tax,$24.10,-560,11065,-5%,"-$13,496",-2.0,3.0,-3.0,-11.0,PGNX
420,D,2007-04-04 15:22:34,2007-04-02,PGNX,Baker Mark Robert,GC,M - OptEx,$20.13,621,11065,+6%,"+$12,501",-2.0,3.0,-3.0,-11.0,PGNX
421,D,2007-04-04 15:16:35,2007-04-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$24.10,-1581,657290,0%,"-$38,102",-2.0,3.0,-3.0,-11.0,PGNX
422,D,2007-04-04 15:16:35,2007-04-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.22,13754,657290,+2%,"+$99,268",-2.0,3.0,-3.0,-11.0,PGNX
423,D,2007-04-04 15:16:35,2007-04-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.85,-12000,657290,-2%,"-$286,152",-2.0,3.0,-3.0,-11.0,PGNX
424,D,2007-03-19 13:51:43,2007-03-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,33676,+6%,"+$32,598",3.0,5.0,17.0,6.0,PGNX
425,D,2007-03-19 13:51:43,2007-03-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$22.79,-2000,33676,-6%,"-$45,582",3.0,5.0,17.0,6.0,PGNX
426,D,2007-03-19 13:50:51,2007-03-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657117,+2%,"+$63,960",3.0,5.0,17.0,6.0,PGNX
427,D,2007-03-19 13:50:51,2007-03-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$22.95,-12000,657117,-2%,"-$275,424",3.0,5.0,17.0,6.0,PGNX
428,D,2007-03-02 15:15:15,2007-03-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,657117,+2%,"+$63,960",-3.0,-12.0,-9.0,-12.0,PGNX
429,D,2007-03-02 15:15:15,2007-03-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$26.49,-12000,657117,-2%,"-$317,832",-3.0,-12.0,-9.0,-12.0,PGNX
430,D,2007-03-02 15:12:12,2007-03-01,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,10000,32181,+45%,"+$40,000",-3.0,-12.0,-9.0,-12.0,PGNX
431,D,2007-03-02 15:12:12,2007-03-01,PGNX,Scheinberg David A,Dir,S - Sale+OE,$25.99,-10000,32181,-24%,"-$259,890",-3.0,-12.0,-9.0,-12.0,PGNX
432,AD,2007-02-28 15:12:43,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,4000,33676,+13%,"+$65,195",3.0,-1.0,-13.0,-14.0,PGNX
433,AD,2007-02-28 15:12:43,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$29.97,-4000,33676,-11%,"-$119,896",3.0,-1.0,-13.0,-14.0,PGNX
434,AD,2007-02-22 12:46:01,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,4000,33676,+13%,"+$65,195",0.0,-6.0,-21.0,-21.0,PGNX
435,AD,2007-02-22 12:46:01,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$29.97,-4000,33676,-11%,"-$119,896",0.0,-6.0,-21.0,-21.0,PGNX
436,,2007-02-22 11:25:59,2007-02-20,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,15957,657117,+2%,+$0,0.0,-6.0,-21.0,-21.0,PGNX
437,D,2007-02-20 15:06:58,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$17.19,4000,33676,+13%,"+$68,760",1.0,-7.0,-22.0,-20.0,PGNX
438,D,2007-02-20 15:06:58,2007-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$29.97,-4000,33676,-11%,"-$119,896",1.0,-7.0,-22.0,-20.0,PGNX
439,D,2007-02-20 10:48:04,2007-02-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,641160,+2%,"+$63,960",1.0,-7.0,-22.0,-20.0,PGNX
440,D,2007-02-20 10:48:04,2007-02-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$29.89,-12000,641160,-2%,"-$358,716",1.0,-7.0,-22.0,-20.0,PGNX
441,D,2007-02-14 13:10:20,2007-02-12,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22694,+21%,"+$16,000",0.0,-2.0,-21.0,-24.0,PGNX
442,D,2007-02-14 13:10:20,2007-02-12,PGNX,McKinney Robert A,CFO,S - Sale+OE,$29.48,-4000,22694,-15%,"-$117,908",0.0,-2.0,-21.0,-24.0,PGNX
443,D,2007-02-06 14:26:55,2007-02-02,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,30000,32181,>999%,"+$120,000",0.0,0.0,-24.0,-26.0,PGNX
444,D,2007-02-06 14:26:55,2007-02-02,PGNX,Scheinberg David A,Dir,S - Sale+OE,$30.11,-30000,32181,-48%,"-$903,150",0.0,0.0,-24.0,-26.0,PGNX
445,D,2007-02-02 16:52:43,2007-02-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,641160,+2%,"+$63,960",-1.0,-1.0,-15.0,-30.0,PGNX
446,D,2007-02-02 16:52:43,2007-02-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$29.89,-12000,641160,-2%,"-$358,632",-1.0,-1.0,-15.0,-30.0,PGNX
447,D,2007-01-31 15:27:42,2007-01-29,PGNX,Baker Charles A,Dir,M - OptEx,$19.50,2500,21481,+13%,"+$48,750",-1.0,-1.0,-13.0,-29.0,PGNX
448,D,2007-01-31 15:27:42,2007-01-29,PGNX,Baker Charles A,Dir,S - Sale+OE,$30.02,-2500,21481,-10%,"-$75,050",-1.0,-1.0,-13.0,-29.0,PGNX
449,D,2007-01-31 15:24:42,2007-01-29,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22694,+21%,"+$16,000",-1.0,-1.0,-13.0,-29.0,PGNX
450,D,2007-01-31 15:24:42,2007-01-29,PGNX,McKinney Robert A,CFO,S - Sale+OE,$29.72,-4000,22694,-15%,"-$118,872",-1.0,-1.0,-13.0,-29.0,PGNX
451,D,2007-01-18 16:07:19,2007-01-16,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22694,+21%,"+$16,000",1.0,5.0,7.0,-23.0,PGNX
452,D,2007-01-18 16:07:19,2007-01-16,PGNX,McKinney Robert A,CFO,S - Sale+OE,$28.79,-4000,22694,-15%,"-$115,160",1.0,5.0,7.0,-23.0,PGNX
453,D,2007-01-18 16:03:01,2007-01-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,641160,+2%,"+$63,960",1.0,5.0,7.0,-23.0,PGNX
454,D,2007-01-18 16:03:01,2007-01-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$28.58,-12000,641160,-2%,"-$342,912",1.0,5.0,7.0,-23.0,PGNX
455,D,2007-01-10 10:13:12,2007-01-08,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,8000,32181,+33%,"+$32,000",2.0,3.0,9.0,-23.0,PGNX
456,D,2007-01-05 15:26:49,2007-01-03,PGNX,Olson William C,"VP, Research, Development",F - Tax,$26.66,-323,24051,-1%,"-$8,611",0.0,4.0,10.0,-19.0,PGNX
457,D,2007-01-05 15:26:49,2007-01-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$21.88,362,24051,+2%,"+$7,921",0.0,4.0,10.0,-19.0,PGNX
458,D,2007-01-05 15:21:49,2007-01-03,PGNX,McKinney Robert A,CFO,F - Tax,$26.66,-382,22694,-2%,"-$10,184",0.0,4.0,10.0,-19.0,PGNX
459,D,2007-01-05 15:21:49,2007-01-03,PGNX,McKinney Robert A,CFO,M - OptEx,$5.73,4428,22694,+24%,"+$25,365",0.0,4.0,10.0,-19.0,PGNX
460,D,2007-01-05 15:21:49,2007-01-03,PGNX,McKinney Robert A,CFO,S - Sale+OE,$25.68,-4000,22694,-15%,"-$102,708",0.0,4.0,10.0,-19.0,PGNX
461,D,2007-01-05 15:09:28,2007-01-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$26.66,-1441,641160,0%,"-$38,417",0.0,4.0,10.0,-19.0,PGNX
462,D,2007-01-05 15:09:28,2007-01-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.29,13614,641160,+2%,"+$99,274",0.0,4.0,10.0,-19.0,PGNX
463,D,2007-01-05 15:09:28,2007-01-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$25.68,-12000,641160,-2%,"-$308,124",0.0,4.0,10.0,-19.0,PGNX
464,D,2007-01-05 15:03:48,2007-01-03,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$26.66,-612,23187,-3%,"-$16,316",0.0,4.0,10.0,-19.0,PGNX
465,D,2007-01-05 15:03:48,2007-01-03,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$21.88,686,23187,+3%,"+$15,010",0.0,4.0,10.0,-19.0,PGNX
466,D,2007-01-05 14:49:09,2007-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$26.66,-574,26810,-2%,"-$15,303",0.0,4.0,10.0,-19.0,PGNX
467,D,2007-01-05 14:49:09,2007-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$21.88,643,26810,+2%,"+$14,069",0.0,4.0,10.0,-19.0,PGNX
468,D,2007-01-05 14:43:34,2007-01-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$26.66,-382,33625,-1%,"-$10,184",0.0,4.0,10.0,-19.0,PGNX
469,D,2007-01-05 14:43:34,2007-01-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$21.88,428,33625,+1%,"+$9,365",0.0,4.0,10.0,-19.0,PGNX
470,D,2007-01-05 14:38:56,2007-01-03,PGNX,Baker Mark Robert,GC,F - Tax,$26.66,-510,10953,-4%,"-$13,597",0.0,4.0,10.0,-19.0,PGNX
471,D,2007-01-05 14:38:56,2007-01-03,PGNX,Baker Mark Robert,GC,M - OptEx,$21.88,571,10953,+5%,"+$12,493",0.0,4.0,10.0,-19.0,PGNX
472,AD,2006-12-22 16:07:10,2006-12-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$13.63,500,33579,+2%,"+$6,813",-1.0,-2.0,11.0,-16.0,PGNX
473,AD,2006-12-22 16:07:10,2006-12-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$26.05,-500,33579,-1%,"-$13,025",-1.0,-2.0,11.0,-16.0,PGNX
474,D,2006-12-19 16:09:56,2006-12-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$17.19,2000,33579,+6%,"+$34,380",1.0,1.0,9.0,-12.0,PGNX
475,D,2006-12-19 16:09:56,2006-12-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$26.05,-2000,33579,-6%,"-$52,100",1.0,1.0,9.0,-12.0,PGNX
476,D,2006-12-19 16:05:35,2006-12-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640987,+2%,"+$63,960",1.0,1.0,9.0,-12.0,PGNX
477,D,2006-12-19 16:05:35,2006-12-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$26.14,-12000,640987,-2%,"-$313,668",1.0,1.0,9.0,-12.0,PGNX
478,D,2006-12-12 15:52:48,2006-12-11,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22597,+22%,"+$16,000",-2.0,-6.0,4.0,-21.0,PGNX
479,D,2006-12-12 15:52:48,2006-12-11,PGNX,McKinney Robert A,CFO,S - Sale+OE,$27.75,-4000,22597,-15%,"-$110,988",-2.0,-6.0,4.0,-21.0,PGNX
480,D,2006-12-06 15:34:03,2006-12-04,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26690,+23%,"+$20,000",0.0,-4.0,-4.0,-22.0,PGNX
481,D,2006-12-06 15:34:03,2006-12-04,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$28.00,-5000,26690,-16%,"-$140,000",0.0,-4.0,-4.0,-22.0,PGNX
482,D,2006-12-05 16:23:31,2006-12-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26690,+23%,"+$20,000",0.0,-2.0,-4.0,-21.0,PGNX
483,D,2006-12-05 16:23:31,2006-12-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$26.91,-5000,26690,-16%,"-$134,565",0.0,-2.0,-4.0,-21.0,PGNX
484,D,2006-12-05 16:19:17,2006-12-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640987,+2%,"+$63,960",0.0,-2.0,-4.0,-21.0,PGNX
485,D,2006-12-05 16:19:17,2006-12-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$26.82,-12000,640987,-2%,"-$321,843",0.0,-2.0,-4.0,-21.0,PGNX
486,D,2006-12-05 15:27:50,2006-12-01,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,10000,24181,+71%,"+$40,000",0.0,-3.0,-4.0,-22.0,PGNX
487,D,2006-12-05 15:27:50,2006-12-01,PGNX,Scheinberg David A,Dir,S - Sale+OE,$27.15,-10000,24181,-29%,"-$271,487",0.0,-3.0,-4.0,-22.0,PGNX
488,D,2006-11-29 15:42:54,2006-11-27,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22597,+22%,"+$16,000",2.0,4.0,-4.0,-17.0,PGNX
489,D,2006-11-29 15:42:54,2006-11-27,PGNX,McKinney Robert A,CFO,S - Sale+OE,$28.05,-4000,22597,-15%,"-$112,188",2.0,4.0,-4.0,-17.0,PGNX
490,D,2006-11-17 17:01:25,2006-11-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.30,2000,33579,+6%,"+$32,598",-1.0,-3.0,-11.0,-24.0,PGNX
491,D,2006-11-17 17:01:25,2006-11-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$28.93,-2000,33579,-6%,"-$57,864",-1.0,-3.0,-11.0,-24.0,PGNX
492,D,2006-11-17 16:22:15,2006-11-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640987,+2%,"+$63,960",-1.0,-3.0,-11.0,-24.0,PGNX
493,D,2006-11-17 16:22:15,2006-11-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$29.15,-12000,640987,-2%,"-$349,752",-1.0,-3.0,-11.0,-24.0,PGNX
494,DM,2006-11-14 13:13:46,2006-11-10,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,8000,22597,+55%,"+$32,000",3.0,1.0,-8.0,-25.0,PGNX
495,DM,2006-11-14 13:13:46,2006-11-10,PGNX,McKinney Robert A,CFO,S - Sale+OE,$28.52,-8000,22597,-26%,"-$228,124",3.0,1.0,-8.0,-25.0,PGNX
496,D,2006-11-14 13:11:08,2006-11-10,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26690,+23%,"+$20,000",3.0,1.0,-8.0,-25.0,PGNX
497,D,2006-11-14 13:11:08,2006-11-10,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$28.00,-5000,26690,-16%,"-$140,000",3.0,1.0,-8.0,-25.0,PGNX
498,D,2006-11-02 13:35:36,2006-11-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22597,+22%,"+$16,000",0.0,4.0,11.0,-4.0,PGNX
499,D,2006-11-02 13:35:36,2006-11-01,PGNX,McKinney Robert A,CFO,S - Sale+OE,$25.96,-4000,22597,-15%,"-$103,856",0.0,4.0,11.0,-4.0,PGNX
500,D,2006-11-02 13:27:00,2006-11-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26690,+23%,"+$20,000",0.0,4.0,11.0,-4.0,PGNX
501,D,2006-11-02 13:27:00,2006-11-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$25.96,-5000,26690,-16%,"-$129,820",0.0,4.0,11.0,-4.0,PGNX
502,D,2006-11-02 13:26:06,2006-11-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640987,+2%,"+$63,960",0.0,4.0,11.0,-4.0,PGNX
503,D,2006-11-02 13:26:06,2006-11-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$25.96,-12000,640987,-2%,"-$311,568",0.0,4.0,11.0,-4.0,PGNX
504,D,2006-10-27 16:40:00,2006-10-27,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,4000,22597,+22%,"+$16,000",0.0,-4.0,7.0,-5.0,PGNX
505,D,2006-10-27 16:40:00,2006-10-27,PGNX,McKinney Robert A,CFO,S - Sale+OE,$26.00,-4000,22597,-15%,"-$104,000",0.0,-4.0,7.0,-5.0,PGNX
506,,2006-10-24 15:20:45,2006-10-20,PGNX,Kremer Alton B,"VP, Clinical Research",A - Grant,$0.00,10000,23062,+77%,+$0,-2.0,3.0,14.0,3.0,PGNX
507,,2006-10-24 15:17:15,2006-10-20,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.00,10000,33579,+42%,+$0,-2.0,3.0,14.0,3.0,PGNX
508,D,2006-10-17 15:07:13,2006-10-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640987,+2%,"+$63,960",2.0,5.0,23.0,7.0,PGNX
509,D,2006-10-17 15:07:13,2006-10-16,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$24.00,-12000,640987,-2%,"-$288,000",2.0,5.0,23.0,7.0,PGNX
510,D,2006-10-04 11:02:04,2006-10-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$23.03,-428,23579,-2%,"-$9,857",4.0,4.0,10.0,8.0,PGNX
511,D,2006-10-04 11:02:04,2006-10-02,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$19.58,470,23579,+2%,"+$9,203",4.0,4.0,10.0,8.0,PGNX
512,D,2006-10-04 10:57:41,2006-10-02,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$23.03,-685,13062,-5%,"-$15,776",4.0,4.0,10.0,8.0,PGNX
513,D,2006-10-04 10:57:41,2006-10-02,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$19.58,752,13062,+6%,"+$14,724",4.0,4.0,10.0,8.0,PGNX
514,D,2006-10-04 10:49:42,2006-10-02,PGNX,Baker Mark Robert,GC,F - Tax,$23.03,-571,10841,-5%,"-$13,150",4.0,4.0,10.0,8.0,PGNX
515,D,2006-10-04 10:49:42,2006-10-02,PGNX,Baker Mark Robert,GC,M - OptEx,$19.58,627,10841,+6%,"+$12,277",4.0,4.0,10.0,8.0,PGNX
516,D,2006-10-04 10:45:50,2006-10-02,PGNX,Olson William C,"VP, Research, Development",F - Tax,$23.03,-362,23961,-1%,"-$8,337",4.0,4.0,10.0,8.0,PGNX
517,D,2006-10-04 10:45:50,2006-10-02,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$19.58,397,23961,+2%,"+$7,773",4.0,4.0,10.0,8.0,PGNX
518,D,2006-10-04 10:41:56,2006-10-02,PGNX,McKinney Robert A,CFO,F - Tax,$23.03,-428,22597,-2%,"-$9,857",4.0,4.0,10.0,8.0,PGNX
519,D,2006-10-04 10:41:56,2006-10-02,PGNX,McKinney Robert A,CFO,M - OptEx,$19.58,470,22597,+2%,"+$9,203",4.0,4.0,10.0,8.0,PGNX
520,D,2006-10-04 10:36:01,2006-10-02,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$23.03,-641,26690,-2%,"-$14,762",4.0,4.0,10.0,8.0,PGNX
521,D,2006-10-04 10:36:01,2006-10-02,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.93,5705,26690,+27%,"+$33,804",4.0,4.0,10.0,8.0,PGNX
522,D,2006-10-04 10:36:01,2006-10-02,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$23.37,-5000,26690,-16%,"-$116,865",4.0,4.0,10.0,8.0,PGNX
523,D,2006-10-04 10:31:13,2006-10-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$23.03,-1612,640987,0%,"-$37,124",4.0,4.0,10.0,8.0,PGNX
524,D,2006-10-04 10:31:13,2006-10-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.16,13771,640987,+2%,"+$98,636",4.0,4.0,10.0,8.0,PGNX
525,D,2006-10-04 10:31:13,2006-10-02,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.37,-12000,640987,-2%,"-$280,476",4.0,4.0,10.0,8.0,PGNX
526,D,2006-09-19 15:59:21,2006-09-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640828,+2%,"+$63,960",-1.0,-4.0,3.0,1.0,PGNX
527,D,2006-09-19 15:59:21,2006-09-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.95,-12000,640828,-2%,"-$287,350",-1.0,-4.0,3.0,1.0,PGNX
528,D,2006-09-06 12:52:48,2006-09-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26579,+23%,"+$20,000",-3.0,-2.0,-6.0,-9.0,PGNX
529,D,2006-09-06 12:52:48,2006-09-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$22.72,-5000,26579,-16%,"-$113,600",-3.0,-2.0,-6.0,-9.0,PGNX
530,D,2006-09-06 12:46:56,2006-09-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640828,+2%,"+$63,960",-3.0,-2.0,-6.0,-9.0,PGNX
531,D,2006-09-06 12:46:56,2006-09-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$22.72,-12000,640828,-2%,"-$272,640",-3.0,-2.0,-6.0,-9.0,PGNX
532,D,2006-08-16 15:18:51,2006-08-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640828,+2%,"+$63,960",3.0,4.0,16.0,43.0,PGNX
533,D,2006-08-16 15:18:51,2006-08-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$20.20,-12000,640828,-2%,"-$242,412",3.0,4.0,16.0,43.0,PGNX
534,D,2006-08-03 16:15:20,2006-08-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,26579,+23%,"+$20,000",-1.0,-8.0,2.0,37.0,PGNX
535,D,2006-08-03 16:15:20,2006-08-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$21.60,-5000,26579,-16%,"-$108,000",-1.0,-8.0,2.0,37.0,PGNX
536,D,2006-08-03 16:11:03,2006-08-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640828,+2%,"+$63,960",-1.0,-8.0,2.0,37.0,PGNX
537,D,2006-08-03 16:11:03,2006-08-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.58,-12000,640828,-2%,"-$258,900",-1.0,-8.0,2.0,37.0,PGNX
538,D,2006-07-19 14:33:51,2006-07-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,12000,640828,+2%,"+$63,960",6.0,5.0,3.0,33.0,PGNX
539,D,2006-07-19 14:33:51,2006-07-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.10,-12000,640828,-2%,"-$253,224",6.0,5.0,3.0,33.0,PGNX
540,D,2006-07-06 17:23:35,2006-07-03,PGNX,Olson William C,"VP, Research, Development",A - Grant,$0.00,6500,23879,+37%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
541,D,2006-07-06 17:23:35,2006-07-03,PGNX,Olson William C,"VP, Research, Development",F - Tax,$24.26,-1237,23879,-5%,"-$30,010",-1.0,-6.0,-9.0,11.0,PGNX
542,D,2006-07-06 17:23:35,2006-07-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$20.45,1365,23879,+6%,"+$27,916",-1.0,-6.0,-9.0,11.0,PGNX
543,D,2006-07-06 17:22:51,2006-07-03,PGNX,Kremer Alton B,"VP, Clinical Research",A - Grant,$0.00,6500,12948,+101%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
544,D,2006-07-06 17:22:51,2006-07-03,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$24.26,-2049,12948,-14%,"-$49,709",-1.0,-6.0,-9.0,11.0,PGNX
545,D,2006-07-06 17:22:51,2006-07-03,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$20.45,2262,12948,+21%,"+$46,260",-1.0,-6.0,-9.0,11.0,PGNX
546,D,2006-07-06 17:22:20,2006-07-03,PGNX,Israel Robert J,"SVP, Medical Affairs",A - Grant,$0.00,6500,26579,+32%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
547,D,2006-07-06 17:22:20,2006-07-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$24.26,-2007,26579,-7%,"-$48,690",-1.0,-6.0,-9.0,11.0,PGNX
548,D,2006-07-06 17:22:20,2006-07-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$9.05,7216,26579,+37%,"+$65,319",-1.0,-6.0,-9.0,11.0,PGNX
549,D,2006-07-06 17:22:20,2006-07-03,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$23.84,-5000,26579,-16%,"-$119,185",-1.0,-6.0,-9.0,11.0,PGNX
550,D,2006-07-06 17:21:38,2006-07-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.00,6500,23490,+38%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
551,D,2006-07-06 17:21:38,2006-07-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$24.26,-1799,23490,-7%,"-$43,644",-1.0,-6.0,-9.0,11.0,PGNX
552,D,2006-07-06 17:21:38,2006-07-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$20.45,1986,23490,+9%,"+$40,616",-1.0,-6.0,-9.0,11.0,PGNX
553,D,2006-07-06 17:21:03,2006-07-03,PGNX,McKinney Robert A,CFO,A - Grant,$0.00,8000,22508,+55%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
554,D,2006-07-06 17:21:03,2006-07-03,PGNX,McKinney Robert A,CFO,F - Tax,$24.26,-2076,22508,-8%,"-$50,364",-1.0,-6.0,-9.0,11.0,PGNX
555,D,2006-07-06 17:21:03,2006-07-03,PGNX,McKinney Robert A,CFO,M - OptEx,$20.45,2292,22508,+11%,"+$46,874",-1.0,-6.0,-9.0,11.0,PGNX
556,D,2006-07-06 17:20:34,2006-07-03,PGNX,Baker Mark Robert,GC,A - Grant,$0.00,8000,10738,+292%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
557,D,2006-07-06 17:20:34,2006-07-03,PGNX,Baker Mark Robert,GC,F - Tax,$24.26,-2768,10738,-20%,"-$67,152",-1.0,-6.0,-9.0,11.0,PGNX
558,D,2006-07-06 17:20:34,2006-07-03,PGNX,Baker Mark Robert,GC,M - OptEx,$25.01,3056,10738,+40%,"+$76,431",-1.0,-6.0,-9.0,11.0,PGNX
559,D,2006-07-06 17:19:55,2006-07-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,48336,640828,+8%,+$0,-1.0,-6.0,-9.0,11.0,PGNX
560,D,2006-07-06 17:19:55,2006-07-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$24.26,-1564,640828,0%,"-$37,943",-1.0,-6.0,-9.0,11.0,PGNX
561,D,2006-07-06 17:19:55,2006-07-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.23,13727,640828,+2%,"+$99,279",-1.0,-6.0,-9.0,11.0,PGNX
562,D,2006-07-06 17:19:55,2006-07-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.84,-12000,640828,-2%,"-$286,044",-1.0,-6.0,-9.0,11.0,PGNX
563,,2006-06-26 11:19:56,2006-06-21,PGNX,Kremer Alton B,"VP, Clinical Research",S - Sale,$21.60,-875,6187,-12%,"-$18,900",0.0,8.0,-2.0,17.0,PGNX
564,,2006-06-23 11:28:12,2006-06-21,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale,$21.62,-12500,592329,-2%,"-$270,263",2.0,5.0,-4.0,17.0,PGNX
565,,2006-06-23 11:27:30,2006-06-21,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale,$21.60,-900,19822,-4%,"-$19,440",2.0,5.0,-4.0,17.0,PGNX
566,,2006-06-23 11:26:48,2006-06-21,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale,$21.64,-3750,16755,-18%,"-$81,139",2.0,5.0,-4.0,17.0,PGNX
567,,2006-06-22 17:08:06,2006-06-20,PGNX,Olson William C,"VP, Research, Development",S - Sale,$21.62,-1000,17203,-5%,"-$21,620",0.0,-1.0,-6.0,16.0,PGNX
568,,2006-06-22 17:07:30,2006-06-20,PGNX,McKinney Robert A,CFO,S - Sale,$21.41,-3000,14244,-17%,"-$64,239",0.0,-1.0,-6.0,16.0,PGNX
569,D,2006-06-16 15:08:38,2006-06-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,9774,604829,+2%,"+$52,095",-5.0,-2.0,-8.0,16.0,PGNX
570,D,2006-06-16 15:08:38,2006-06-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$22.00,-9774,604829,-2%,"-$215,054",-5.0,-2.0,-8.0,16.0,PGNX
571,D,2006-06-05 16:25:45,2006-06-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,20722,+32%,"+$20,000",-4.0,2.0,11.0,25.0,PGNX
572,D,2006-06-05 16:25:45,2006-06-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$21.84,-5000,20722,-19%,"-$109,220",-4.0,2.0,11.0,25.0,PGNX
573,D,2006-06-05 16:01:46,2006-06-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,604829,+2%,"+$53,300",-4.0,2.0,11.0,25.0,PGNX
574,D,2006-06-05 16:01:46,2006-06-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$21.82,-10000,604829,-2%,"-$218,152",-4.0,2.0,11.0,25.0,PGNX
575,D,2006-05-17 15:20:00,2006-05-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,604829,+2%,"+$53,300",-5.0,-4.0,4.0,32.0,PGNX
576,D,2006-05-17 15:20:00,2006-05-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$20.91,-10000,604829,-2%,"-$209,090",-5.0,-4.0,4.0,32.0,PGNX
577,DM,2006-05-08 12:32:22,2006-05-04,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.00,14000,18203,+333%,"+$56,000",-3.0,-12.0,-14.0,3.0,PGNX
578,DM,2006-05-08 12:32:22,2006-05-04,PGNX,Olson William C,"VP, Research, Development",S - Sale+OE,$24.00,-14000,18203,-43%,"-$336,000",-3.0,-12.0,-14.0,3.0,PGNX
579,D,2006-05-03 13:50:56,2006-05-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,604829,+2%,"+$53,300",1.0,1.0,-5.0,11.0,PGNX
580,D,2006-05-03 13:50:56,2006-05-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$23.52,-10000,604829,-2%,"-$235,200",1.0,1.0,-5.0,11.0,PGNX
581,D,2006-05-02 14:12:02,2006-05-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,5000,20722,+32%,"+$20,000",3.0,5.0,-8.0,13.0,PGNX
582,D,2006-05-02 14:12:02,2006-05-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$23.51,-5000,20722,-19%,"-$117,550",3.0,5.0,-8.0,13.0,PGNX
583,D,2006-04-18 17:17:05,2006-04-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,604829,+2%,"+$53,300",-2.0,-8.0,-15.0,-7.0,PGNX
584,D,2006-04-18 17:17:05,2006-04-17,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$25.00,-10000,604829,-2%,"-$250,025",-2.0,-8.0,-15.0,-7.0,PGNX
585,D,2006-04-05 16:59:20,2006-04-03,PGNX,Olson William C,"VP, Research, Development",F - Tax,$25.61,-277,18203,-1%,"-$7,094",-5.0,-7.0,-10.0,-13.0,PGNX
586,D,2006-04-05 16:59:20,2006-04-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$21.77,305,18203,+2%,"+$6,640",-5.0,-7.0,-10.0,-13.0,PGNX
587,D,2006-04-05 16:58:48,2006-04-03,PGNX,McKinney Robert A,CFO,F - Tax,$25.61,-327,17244,-2%,"-$8,374",-5.0,-7.0,-10.0,-13.0,PGNX
588,D,2006-04-05 16:58:48,2006-04-03,PGNX,McKinney Robert A,CFO,M - OptEx,$21.77,361,17244,+2%,"+$7,859",-5.0,-7.0,-10.0,-13.0,PGNX
589,D,2006-04-05 16:57:46,2006-04-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$25.61,-341,20505,-2%,"-$8,733",-5.0,-7.0,-10.0,-13.0,PGNX
590,D,2006-04-05 16:57:46,2006-04-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$21.77,376,20505,+2%,"+$8,185",-5.0,-7.0,-10.0,-13.0,PGNX
591,D,2006-04-05 16:56:28,2006-04-03,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$25.61,-555,7062,-7%,"-$14,214",-5.0,-7.0,-10.0,-13.0,PGNX
592,D,2006-04-05 16:56:28,2006-04-03,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$21.77,611,7062,+9%,"+$13,301",-5.0,-7.0,-10.0,-13.0,PGNX
593,D,2006-04-05 16:45:56,2006-04-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$25.61,-534,20722,-3%,"-$13,676",-5.0,-7.0,-10.0,-13.0,PGNX
594,D,2006-04-05 16:45:56,2006-04-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$5.87,5588,20722,+37%,"+$32,800",-5.0,-7.0,-10.0,-13.0,PGNX
595,D,2006-04-05 16:45:56,2006-04-03,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$26.16,-5000,20722,-19%,"-$130,780",-5.0,-7.0,-10.0,-13.0,PGNX
596,D,2006-04-05 16:45:22,2006-04-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$25.61,-1356,604829,0%,"-$34,727",-5.0,-7.0,-10.0,-13.0,PGNX
597,D,2006-04-05 16:45:22,2006-04-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$7.46,11490,604829,+2%,"+$85,736",-5.0,-7.0,-10.0,-13.0,PGNX
598,D,2006-04-05 16:45:22,2006-04-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$25.86,-10000,604829,-2%,"-$258,643",-5.0,-7.0,-10.0,-13.0,PGNX
599,D,2006-04-05 16:31:24,2006-04-03,PGNX,Baker Mark Robert,GC,F - Tax,$25.61,-454,2402,-16%,"-$11,627",-5.0,-7.0,-10.0,-13.0,PGNX
600,D,2006-04-05 16:31:24,2006-04-03,PGNX,Baker Mark Robert,GC,M - OptEx,$21.77,500,2402,+26%,"+$10,885",-5.0,-7.0,-10.0,-13.0,PGNX
601,D,2006-03-21 16:00:15,2006-03-20,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.00,2000,18135,+12%,"+$8,000",-1.0,1.0,-8.0,-13.0,PGNX
602,D,2006-03-21 16:00:15,2006-03-20,PGNX,Olson William C,"VP, Research, Development",S - Sale+OE,$27.46,-2000,18135,-10%,"-$54,920",-1.0,1.0,-8.0,-13.0,PGNX
603,D,2006-03-17 14:55:25,2006-03-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,604695,+2%,"+$53,300",1.0,1.0,-7.0,-11.0,PGNX
604,D,2006-03-17 14:55:25,2006-03-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$27.00,-10000,604695,-2%,"-$270,040",1.0,1.0,-7.0,-11.0,PGNX
605,D,2006-03-07 15:35:48,2006-02-27,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,5000,24181,+26%,"+$20,000",-1.0,-2.0,-6.0,-19.0,PGNX
606,D,2006-03-07 15:35:48,2006-02-27,PGNX,Scheinberg David A,Dir,S - Sale+OE,$30.02,-5000,24181,-17%,"-$150,100",-1.0,-2.0,-6.0,-19.0,PGNX
607,,2006-03-06 15:09:13,2006-03-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.00,18080,604695,+3%,+$0,-4.0,-6.0,-12.0,-22.0,PGNX
608,D,2006-03-03 11:44:22,2006-03-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,586615,+2%,"+$53,300",-4.0,-6.0,-9.0,-21.0,PGNX
609,D,2006-03-03 11:44:22,2006-03-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$29.02,-10000,586615,-2%,"-$290,210",-4.0,-6.0,-9.0,-21.0,PGNX
610,D,2006-03-02 11:57:03,2006-03-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,10000,20628,+94%,"+$40,000",-1.0,-6.0,-8.0,-21.0,PGNX
611,D,2006-03-02 11:57:03,2006-03-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$29.02,-10000,20628,-33%,"-$290,210",-1.0,-6.0,-8.0,-21.0,PGNX
612,D,2006-03-01 17:17:40,2006-02-06,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.00,2000,18135,+12%,"+$8,000",-1.0,-5.0,-9.0,-25.0,PGNX
613,D,2006-03-01 17:17:40,2006-02-06,PGNX,Olson William C,"VP, Research, Development",S - Sale+OE,$24.45,-2000,18135,-10%,"-$48,906",-1.0,-5.0,-9.0,-25.0,PGNX
614,,2006-03-01 17:12:10,2006-02-27,PGNX,McKinney Robert A,CFO,S - Sale,$30.00,-1500,17170,-8%,"-$45,000",-1.0,-5.0,-9.0,-25.0,PGNX
615,D,2006-02-23 16:19:00,2006-02-21,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$4.00,2000,18135,+12%,"+$8,000",2.0,3.0,-4.0,-24.0,PGNX
616,D,2006-02-23 16:19:00,2006-02-21,PGNX,Olson William C,"VP, Research, Development",S - Sale+OE,$28.01,-2000,18135,-10%,"-$56,020",2.0,3.0,-4.0,-24.0,PGNX
617,D,2006-02-17 11:28:22,2006-02-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,586615,+2%,"+$53,300",-3.0,2.0,-4.0,-23.0,PGNX
618,D,2006-02-17 11:28:22,2006-02-15,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$27.17,-10000,586615,-2%,"-$271,680",-3.0,2.0,-4.0,-23.0,PGNX
619,D,2006-02-17 11:25:20,2006-02-15,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,1858,20628,+10%,"+$7,432",-3.0,2.0,-4.0,-23.0,PGNX
620,D,2006-02-17 11:25:20,2006-02-15,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$28.00,-1858,20628,-8%,"-$52,024",-3.0,2.0,-4.0,-23.0,PGNX
621,D,2006-02-17 11:22:32,2006-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$13.63,10000,20430,+96%,"+$136,250",-3.0,2.0,-4.0,-23.0,PGNX
622,D,2006-02-17 11:22:32,2006-02-15,PGNX,Boyd Thomas A,"SVP, Product Dev.",S - Sale+OE,$28.00,-10000,20430,-33%,"-$280,000",-3.0,2.0,-4.0,-23.0,PGNX
623,D,2006-02-03 16:38:39,2006-02-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,8142,20628,+65%,"+$32,568",-3.0,-6.0,2.0,-19.0,PGNX
624,D,2006-02-03 16:38:39,2006-02-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$27.84,-8142,20628,-28%,"-$226,646",-3.0,-6.0,2.0,-19.0,PGNX
625,D,2006-02-03 16:18:53,2006-02-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$5.33,10000,586615,+2%,"+$53,300",-3.0,-6.0,2.0,-19.0,PGNX
626,D,2006-02-03 16:18:53,2006-02-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",S - Sale+OE,$27.73,-10000,586615,-2%,"-$277,270",-3.0,-6.0,2.0,-19.0,PGNX
627,D,2006-02-01 16:06:35,2006-01-30,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$13.57,8000,6966,-774%,"+$108,560",1.0,-3.0,6.0,-22.0,PGNX
628,D,2006-02-01 16:06:35,2006-01-30,PGNX,Kremer Alton B,"VP, Clinical Research",S - Sale+OE,$27.63,-8000,6966,-53%,"-$221,064",1.0,-3.0,6.0,-22.0,PGNX
629,D,2006-01-05 17:26:44,2006-01-03,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$25.84,-583,6966,-8%,"-$15,065",9.0,11.0,3.0,-9.0,PGNX
630,D,2006-01-05 17:26:44,2006-01-03,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$20.86,659,6966,+10%,"+$13,747",9.0,11.0,3.0,-9.0,PGNX
631,D,2006-01-05 17:18:51,2006-01-03,PGNX,Olson William C,"VP, Research, Development",F - Tax,$25.84,-291,18135,-2%,"-$7,519",9.0,11.0,3.0,-9.0,PGNX
632,D,2006-01-05 17:18:51,2006-01-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$20.86,330,18135,+2%,"+$6,884",9.0,11.0,3.0,-9.0,PGNX
633,D,2006-01-05 17:17:04,2006-01-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$25.84,-324,20430,-2%,"-$8,372",9.0,11.0,3.0,-9.0,PGNX
634,D,2006-01-05 17:17:04,2006-01-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$20.86,367,20430,+2%,"+$7,656",9.0,11.0,3.0,-9.0,PGNX
635,D,2006-01-05 17:15:30,2006-01-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$25.84,-1422,586615,0%,"-$36,744",9.0,11.0,3.0,-9.0,PGNX
636,D,2006-01-05 17:15:30,2006-01-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$20.86,1608,586615,0%,"+$33,543",9.0,11.0,3.0,-9.0,PGNX
637,D,2006-01-05 17:12:57,2006-01-03,PGNX,Baker Mark Robert,GC,F - Tax,$25.84,-477,2316,-17%,"-$12,326",9.0,11.0,3.0,-9.0,PGNX
638,D,2006-01-05 17:12:57,2006-01-03,PGNX,Baker Mark Robert,GC,M - OptEx,$20.86,539,2316,+30%,"+$11,244",9.0,11.0,3.0,-9.0,PGNX
639,D,2006-01-05 17:10:31,2006-01-03,PGNX,McKinney Robert A,CFO,F - Tax,$25.84,-344,18670,-2%,"-$8,889",9.0,11.0,3.0,-9.0,PGNX
640,D,2006-01-05 17:10:31,2006-01-03,PGNX,McKinney Robert A,CFO,M - OptEx,$20.86,390,18670,+2%,"+$8,135",9.0,11.0,3.0,-9.0,PGNX
641,D,2006-01-05 17:08:41,2006-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$24.84,-561,20628,-3%,"-$13,935",9.0,11.0,3.0,-9.0,PGNX
642,D,2006-01-05 17:08:41,2006-01-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$20.86,635,20628,+3%,"+$13,246",9.0,11.0,3.0,-9.0,PGNX
643,D,2005-12-20 16:22:39,2005-12-19,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,8750,20496,+74%,"+$35,000",3.0,14.0,25.0,0.0,PGNX
644,D,2005-12-20 16:22:39,2005-12-19,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$22.38,-8750,20496,-30%,"-$195,843",3.0,14.0,25.0,0.0,PGNX
645,D,2005-10-05 15:39:40,2005-10-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",F - Tax,$24.67,-290,20329,-1%,"-$7,154",-4.0,-12.0,-4.0,7.0,PGNX
646,D,2005-10-05 15:39:40,2005-10-03,PGNX,Boyd Thomas A,"SVP, Product Dev.",M - OptEx,$16.81,358,20329,+2%,"+$6,018",-4.0,-12.0,-4.0,7.0,PGNX
647,D,2005-10-05 15:38:21,2005-10-03,PGNX,Kremer Alton B,"VP, Clinical Research",F - Tax,$24.67,-662,6832,-9%,"-$16,332",-4.0,-12.0,-4.0,7.0,PGNX
648,D,2005-10-05 15:38:21,2005-10-03,PGNX,Kremer Alton B,"VP, Clinical Research",M - OptEx,$16.81,818,6832,+14%,"+$13,751",-4.0,-12.0,-4.0,7.0,PGNX
649,D,2005-10-05 15:36:49,2005-10-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",F - Tax,$24.67,-1614,586429,0%,"-$39,817",-4.0,-12.0,-4.0,7.0,PGNX
650,D,2005-10-05 15:36:49,2005-10-03,PGNX,Maddon Paul J,"CEO, CSO, 10%",M - OptEx,$16.81,1996,586429,0%,"+$33,553",-4.0,-12.0,-4.0,7.0,PGNX
651,D,2005-10-05 15:35:42,2005-10-03,PGNX,Olson William C,"VP, Research, Development",F - Tax,$24.67,-331,18038,-2%,"-$8,166",-4.0,-12.0,-4.0,7.0,PGNX
652,D,2005-10-05 15:35:42,2005-10-03,PGNX,Olson William C,"VP, Research, Development",M - OptEx,$16.81,409,18038,+2%,"+$6,875",-4.0,-12.0,-4.0,7.0,PGNX
653,D,2005-10-05 15:34:34,2005-10-03,PGNX,Israel Robert J,"SVP, Medical Affairs",F - Tax,$24.67,-637,20496,-3%,"-$15,715",-4.0,-12.0,-4.0,7.0,PGNX
654,D,2005-10-05 15:34:34,2005-10-03,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$16.81,788,20496,+4%,"+$13,246",-4.0,-12.0,-4.0,7.0,PGNX
655,D,2005-10-05 15:33:24,2005-10-03,PGNX,Baker Mark Robert,GC,A - Grant,$24.67,709,2196,+48%,"+$17,491",-4.0,-12.0,-4.0,7.0,PGNX
656,D,2005-10-05 15:31:50,2005-10-03,PGNX,McKinney Robert A,CFO,F - Tax,$24.67,-391,18566,-2%,"-$9,646",-4.0,-12.0,-4.0,7.0,PGNX
657,D,2005-10-05 15:31:50,2005-10-03,PGNX,McKinney Robert A,CFO,M - OptEx,$16.81,483,18566,+3%,"+$8,119",-4.0,-12.0,-4.0,7.0,PGNX
658,M,2005-09-14 09:38:56,2005-09-12,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale,$25.00,-5000,20155,-20%,"-$125,000",-5.0,-3.0,-16.0,10.0,PGNX
659,D,2005-08-03 19:44:57,2005-08-01,PGNX,McKinney Robert A,CFO,M - OptEx,$4.00,12000,18284,+191%,"+$48,000",-2.0,-6.0,-2.0,14.0,PGNX
660,D,2005-08-03 19:44:57,2005-08-01,PGNX,McKinney Robert A,CFO,S - Sale+OE,$23.43,-12000,18284,-40%,"-$281,100",-2.0,-6.0,-2.0,14.0,PGNX
661,D,2005-07-13 16:00:57,2005-07-11,PGNX,Scheinberg David A,Dir,G - Gift,$0.00,468,24181,+2%,+$0,0.0,3.0,3.0,36.0,PGNX
662,D,2005-07-13 16:00:57,2005-07-11,PGNX,Scheinberg David A,Dir,M - OptEx,$13.50,4000,24181,+20%,"+$54,000",0.0,3.0,3.0,36.0,PGNX
663,D,2005-07-06 21:52:25,2005-07-01,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,2000,23713,+9%,"+$8,000",-2.0,3.0,8.0,16.0,PGNX
664,D,2005-07-06 21:52:25,2005-07-01,PGNX,Scheinberg David A,Dir,S - Sale+OE,$20.85,-2000,23713,-8%,"-$41,700",-2.0,3.0,8.0,16.0,PGNX
665,D,2005-07-06 21:25:07,2005-07-01,PGNX,Baker Mark Robert,GC,A - Grant,$17.73,987,1487,+197%,"+$17,500",-2.0,3.0,8.0,16.0,PGNX
666,D,2005-07-06 21:21:03,2005-07-01,PGNX,Olson William C,"VP, Research, Development",A - Grant,$0.59,4659,17770,+36%,"+$2,728",-2.0,3.0,8.0,16.0,PGNX
667,D,2005-07-06 21:19:57,2005-07-01,PGNX,Kremer Alton B,"VP, Clinical Research",A - Grant,$0.87,3687,6486,+132%,"+$3,209",-2.0,3.0,8.0,16.0,PGNX
668,D,2005-07-06 21:19:04,2005-07-01,PGNX,Israel Robert J,"SVP, Medical Affairs",A - Grant,$0.83,3678,25155,+17%,"+$3,054",-2.0,3.0,8.0,16.0,PGNX
669,D,2005-07-06 21:18:06,2005-07-01,PGNX,Maddon Paul J,"CEO, CSO, 10%",A - Grant,$0.33,25492,586047,+5%,"+$8,443",-2.0,3.0,8.0,16.0,PGNX
670,D,2005-07-06 21:16:42,2005-07-01,PGNX,Boyd Thomas A,"SVP, Product Dev.",A - Grant,$0.33,7645,20071,+62%,"+$2,488",-2.0,3.0,8.0,16.0,PGNX
671,D,2005-07-06 21:02:12,2005-07-01,PGNX,McKinney Robert A,CFO,A - Grant,$0.59,4659,18284,+34%,"+$2,728",-2.0,3.0,8.0,16.0,PGNX
672,,2005-06-22 16:42:33,2005-06-20,PGNX,Boyd Thomas A,"SVP, Product Development",S - Sale,$19.85,-750,12426,-6%,"-$14,888",-1.0,3.0,11.0,9.0,PGNX
673,,2005-06-22 16:41:49,2005-06-21,PGNX,Olson William C,"VP, Research, Development",S - Sale,$20.00,-650,13111,-5%,"-$13,000",-1.0,3.0,11.0,9.0,PGNX
674,,2005-06-22 16:40:51,2005-06-21,PGNX,Maddon Paul J,"CEO, CSO",S - Sale,$20.03,-6250,599303,-1%,"-$125,163",-1.0,3.0,11.0,9.0,PGNX
675,,2005-06-22 16:40:12,2005-06-20,PGNX,Jacobson Paul F,Co-Chairman,S - Sale,$19.85,-3000,188100,-2%,"-$59,550",-1.0,3.0,11.0,9.0,PGNX
676,,2005-06-22 16:39:32,2005-06-20,PGNX,McKinney Robert A,Cheif Financial Officer,S - Sale,$19.87,-750,13625,-5%,"-$14,903",-1.0,3.0,11.0,9.0,PGNX
677,,2005-06-22 16:38:50,2005-06-20,PGNX,Goff Stephen P,Dir,S - Sale,$19.85,-3000,33500,-8%,"-$59,550",-1.0,3.0,11.0,9.0,PGNX
678,,2005-06-22 16:38:08,2005-06-20,PGNX,Israel Robert J,SVP Medical Affairs,S - Sale,$19.87,-750,21477,-3%,"-$14,903",-1.0,3.0,11.0,9.0,PGNX
679,D,2005-04-05 16:28:42,2005-04-01,PGNX,McKinney Robert A,"VP, Finance, Operations",A - Grant,$13.60,40,14375,0%,+$544,4.0,2.0,4.0,42.0,PGNX
680,D,2005-04-05 16:27:45,2005-04-01,PGNX,Maddon Paul J,"CEO, CSO",A - Grant,$13.60,203,567805,0%,"+$2,761",4.0,2.0,4.0,42.0,PGNX
681,D,2005-04-05 16:27:15,2005-04-01,PGNX,Israel Robert J,"Senior VP, Medical Affairs",A - Grant,$13.60,80,22227,0%,"+$1,088",4.0,2.0,4.0,42.0,PGNX
682,D,2005-02-28 17:52:21,2005-02-24,PGNX,McKinney Robert A,"VP, Finance, Oper",M - OptEx,$4.00,3000,14271,+27%,"+$12,000",-2.0,-12.0,-24.0,-2.0,PGNX
683,D,2005-02-28 17:52:21,2005-02-24,PGNX,McKinney Robert A,"VP, Finance, Oper",S - Sale+OE,$24.00,-3000,14271,-17%,"-$72,000",-2.0,-12.0,-24.0,-2.0,PGNX
684,D,2005-02-17 18:34:09,2005-01-03,PGNX,McKinney Robert A,"VP, Finance, Operations",M - OptEx,$16.79,44,14271,0%,+$739,0.0,11.0,-11.0,0.0,PGNX
685,D,2005-02-17 18:32:27,2005-01-03,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$16.79,82,22083,0%,"+$1,377",0.0,11.0,-11.0,0.0,PGNX
686,D,2005-02-17 18:30:23,2005-01-03,PGNX,Maddon Paul J,"CEO, CSO",M - OptEx,$16.79,200,542602,0%,"+$3,358",0.0,11.0,-11.0,0.0,PGNX
687,D,2005-02-17 18:27:58,2005-01-03,PGNX,Prentki Ronald J,Pres,M - OptEx,$16.79,110,33539,0%,"+$1,847",0.0,11.0,-11.0,0.0,PGNX
688,DM,2005-02-07 17:54:30,2005-02-04,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,26000,33578,+343%,"+$240,500",0.0,4.0,-8.0,8.0,PGNX
689,DM,2005-02-07 17:54:30,2005-02-04,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$21.09,-26000,33578,-44%,"-$548,340",0.0,4.0,-8.0,8.0,PGNX
690,DM,2005-02-03 20:35:29,2005-02-01,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,17000,33578,+103%,"+$157,250",0.0,1.0,-5.0,14.0,PGNX
691,DM,2005-02-03 20:35:29,2005-02-01,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$20.38,-17000,33578,-34%,"-$346,400",0.0,1.0,-5.0,14.0,PGNX
692,D,2005-02-01 17:39:38,2005-01-31,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,23000,17778,-440%,"+$212,750",0.0,3.0,10.0,14.0,PGNX
693,D,2005-02-01 17:39:38,2005-01-31,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.92,-23000,17778,-56%,"-$458,208",0.0,3.0,10.0,14.0,PGNX
694,DM,2005-01-25 20:02:03,2005-01-21,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,13000,17778,+272%,"+$120,250",0.0,4.0,15.0,16.0,PGNX
695,DM,2005-01-25 20:02:03,2005-01-21,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.16,-13000,17778,-42%,"-$249,090",0.0,4.0,15.0,16.0,PGNX
696,,2005-01-12 17:26:32,2005-01-10,PGNX,Maddon Paul J,"CEO, CSO",A - Grant,$0.00,25000,670228,+4%,+$0,0.0,2.0,47.0,47.0,PGNX
697,D,2004-12-28 10:15:28,2004-12-22,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$4.00,10000,14120,+243%,"+$40,000",3.0,0.0,15.0,22.0,PGNX
698,D,2004-12-28 10:15:28,2004-12-22,PGNX,Israel Robert J,"SVP, Medical",S - Sale+OE,$16.43,-5000,14120,-26%,"-$82,154",3.0,0.0,15.0,22.0,PGNX
699,D,2004-12-28 10:14:16,2004-12-22,PGNX,Scheinberg David A,Dir,M - OptEx,$4.00,8000,21963,+57%,"+$32,000",3.0,0.0,15.0,22.0,PGNX
700,D,2004-12-28 10:14:16,2004-12-22,PGNX,Scheinberg David A,Dir,S - Sale+OE,$17.00,-4000,21963,-15%,"-$68,000",3.0,0.0,15.0,22.0,PGNX
701,,2004-10-06 17:38:31,2004-10-01,PGNX,McKinney Robert A,"VP, Finance, Admi",M - OptEx,$8.05,109,6453,+2%,+$877,-2.0,-4.0,1.0,22.0,PGNX
702,,2004-10-04 16:57:46,2004-10-01,PGNX,Scheinberg David A,Dir,M - OptEx,$5.69,1250,17963,+7%,"+$7,114",-3.0,-7.0,1.0,13.0,PGNX
703,,2004-10-04 16:32:58,2004-10-01,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$9.98,155,9120,+2%,"+$1,547",-3.0,-7.0,1.0,13.0,PGNX
704,,2004-10-04 16:31:40,2004-10-01,PGNX,Maddon Paul J,"COB, Chief E",M - OptEx,$14.63,556,645028,0%,"+$8,134",-3.0,-7.0,1.0,13.0,PGNX
705,,2004-10-04 15:36:15,2004-10-01,PGNX,Prentki Ronald J,Pres,A - Grant,$10.77,187,17182,+1%,"+$2,014",-1.0,-8.0,0.0,12.0,PGNX
706,,2004-08-04 08:02:45,2004-08-03,PGNX,Scheinberg David A,Dir,M - OptEx,$12.00,1275,16713,+8%,"+$15,300",-1.0,-24.0,-10.0,72.0,PGNX
707,D,2004-07-06 21:05:39,2004-07-06,PGNX,Maddon Paul J,"COB, Chief E",A - Grant,$16.40,196,644472,0%,"+$3,214",-1.0,-8.0,-26.0,6.0,PGNX
708,D,2004-07-06 19:49:24,2004-07-01,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$11.79,177,8965,+2%,"+$2,087",-1.0,-8.0,-26.0,6.0,PGNX
709,D,2004-07-06 19:16:46,2004-07-01,PGNX,McKinney Robert A,"VP, Finance, Admi",A - Grant,$11.79,177,6344,+3%,"+$2,087",-1.0,-8.0,-26.0,6.0,PGNX
710,D,2004-07-06 19:05:30,2004-07-01,PGNX,Prentki Ronald J,Pres,A - Grant,$14.15,361,16995,+2%,"+$5,108",-1.0,-8.0,-26.0,6.0,PGNX
711,DM,2004-06-03 16:52:25,2004-06-01,PGNX,Israel Robert J,"SVP, Medical Affairs",M - OptEx,$4.00,6750,8788,+331%,"+$27,000",0.0,-4.0,-1.0,-8.0,PGNX
712,DM,2004-06-03 16:52:25,2004-06-01,PGNX,Israel Robert J,"SVP, Medical Affairs",S - Sale+OE,$16.93,-6750,8788,-43%,"-$114,273",0.0,-4.0,-1.0,-8.0,PGNX
713,D,2004-05-11 16:25:23,2004-05-07,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,2000,16634,+14%,"+$18,500",0.0,-4.0,-16.0,-23.0,PGNX
714,D,2004-05-11 16:25:23,2004-05-07,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.38,-2000,16634,-11%,"-$38,750",0.0,-4.0,-16.0,-23.0,PGNX
715,DM,2004-05-07 14:46:08,2004-05-05,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,7000,16634,+73%,"+$64,750",-2.0,-4.0,-15.0,-27.0,PGNX
716,DM,2004-05-07 14:46:08,2004-05-05,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.55,-7000,16634,-30%,"-$136,825",-2.0,-4.0,-15.0,-27.0,PGNX
717,D,2004-05-05 17:18:23,2004-05-03,PGNX,Yachmetz Philip K,"VP, GC",M - OptEx,$12.29,2000,7896,+34%,"+$24,580",0.0,-4.0,-15.0,-25.0,PGNX
718,D,2004-05-05 17:18:23,2004-05-03,PGNX,Yachmetz Philip K,"VP, GC",S - Sale+OE,$19.25,-2000,7896,-20%,"-$38,502",0.0,-4.0,-15.0,-25.0,PGNX
719,DM,2004-05-05 15:43:08,2004-05-03,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,8000,16634,+93%,"+$74,000",-1.0,-5.0,-17.0,-26.0,PGNX
720,DM,2004-05-05 15:43:08,2004-05-03,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.41,-8000,16634,-32%,"-$155,290",-1.0,-5.0,-17.0,-26.0,PGNX
721,DM,2004-05-05 15:42:18,2004-05-03,PGNX,Israel Robert J,"Senor VP, Medical Affairs",M - OptEx,$4.00,6500,8788,+284%,"+$26,000",-1.0,-5.0,-17.0,-26.0,PGNX
722,DM,2004-05-05 15:42:18,2004-05-03,PGNX,Israel Robert J,"Senor VP, Medical Affairs",S - Sale+OE,$19.36,-6500,8788,-43%,"-$125,815",-1.0,-5.0,-17.0,-26.0,PGNX
723,DM,2004-04-28 15:56:53,2004-04-26,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,8000,16634,+93%,"+$74,000",0.0,0.0,-10.0,-25.0,PGNX
724,DM,2004-04-28 15:56:53,2004-04-26,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.95,-8000,16634,-32%,"-$159,570",0.0,0.0,-10.0,-25.0,PGNX
725,DM,2004-04-26 16:22:35,2004-04-22,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,11000,16634,+195%,"+$101,750",0.0,0.0,-12.0,-26.0,PGNX
726,DM,2004-04-26 16:22:35,2004-04-22,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.91,-11000,16634,-40%,"-$218,965",0.0,0.0,-12.0,-26.0,PGNX
727,DM,2004-04-21 16:36:38,2004-04-19,PGNX,Prentki Ronald J,Pres,M - OptEx,$9.25,11000,16634,+195%,"+$101,750",0.0,0.0,-6.0,-30.0,PGNX
728,DM,2004-04-21 16:36:38,2004-04-19,PGNX,Prentki Ronald J,Pres,S - Sale+OE,$19.78,-11000,16634,-40%,"-$217,625",0.0,0.0,-6.0,-30.0,PGNX
729,,2004-04-05 16:41:05,2004-04-01,PGNX,Prentki Ronald J,Pres,A - Grant,$11.51,142,16634,+1%,"+$1,634",-2.0,4.0,1.0,-27.0,PGNX
730,D,2004-04-05 16:38:33,2004-04-01,PGNX,McKinney Robert A,"VP, Finance, Admi",A - Grant,$6.35,83,6167,+1%,+$527,-2.0,4.0,1.0,-27.0,PGNX
731,D,2004-04-05 16:34:01,2004-04-01,PGNX,Israel Robert J,"SVP, Medical",A - Grant,$10.05,118,8788,+1%,"+$1,186",-2.0,4.0,1.0,-27.0,PGNX
732,DM,2004-04-05 16:34:01,2004-04-01,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$4.00,6500,8788,+284%,"+$26,000",-2.0,4.0,1.0,-27.0,PGNX
733,DM,2004-04-05 16:34:01,2004-04-01,PGNX,Israel Robert J,"SVP, Medical",S - Sale+OE,$18.63,-6500,8788,-43%,"-$121,115",-2.0,4.0,1.0,-27.0,PGNX
734,,2004-04-05 16:20:51,2004-04-01,PGNX,Maddon Paul J,"COB, CEO",A - Grant,$18.71,174,644276,0%,"+$3,256",-2.0,4.0,1.0,-27.0,PGNX
735,,2004-04-05 16:19:08,2004-04-01,PGNX,Yachmetz Philip K,"VP, GC, Secy",A - Grant,$8.30,98,7932,+1%,+$813,-2.0,4.0,1.0,-27.0,PGNX
736,DM,2004-03-03 15:41:18,2004-03-01,PGNX,Israel Robert J,"SVP, Medical",M - OptEx,$4.00,6500,8670,+300%,"+$26,000",1.0,-1.0,-12.0,-51.0,PGNX
737,DM,2004-03-03 15:41:18,2004-03-01,PGNX,Israel Robert J,"SVP, Medical",S - Sale+OE,$21.91,-6500,8670,-43%,"-$142,420",1.0,-1.0,-12.0,-51.0,PGNX
738,DM,2004-02-20 15:37:37,2004-02-17,PGNX,McKinney Robert A,"VP, Finance, Administration",M - OptEx,$4.00,7500,6084,-530%,"+$30,000",-2.0,-1.0,-12.0,-57.0,PGNX
739,DM,2004-02-20 15:37:37,2004-02-17,PGNX,McKinney Robert A,"VP, Finance, Administration",S - Sale+OE,$21.50,-7500,6084,-55%,"-$161,260",-2.0,-1.0,-12.0,-57.0,PGNX
740,D,2004-01-06 16:44:21,2003-12-18,PGNX,Scheinberg David A,Dir,M - OptEx,$5.33,3500,15438,+29%,"+$18,655",4.0,12.0,19.0,-14.0,PGNX
741,,2004-01-06 16:43:15,2004-01-05,PGNX,McKinney Robert A,"VP, Finance, Administration",A - Grant,$5.93,129,6084,+2%,+$765,4.0,12.0,19.0,-14.0,PGNX
742,,2004-01-06 16:42:33,2004-01-05,PGNX,Yachmetz Philip K,"VP, GC, Secretary",A - Grant,$8.01,153,7834,+2%,"+$1,226",4.0,12.0,19.0,-14.0,PGNX
743,,2004-01-06 16:19:58,2004-01-05,PGNX,Maddon Paul J,"COB, CEO",A - Grant,$19.17,267,644102,0%,"+$5,118",4.0,12.0,19.0,-14.0,PGNX
744,,2004-01-06 16:16:24,2004-01-05,PGNX,Israel Robert J,"SVP, Medical",A - Grant,$9.92,184,8670,+2%,"+$1,825",4.0,12.0,19.0,-14.0,PGNX
745,,2004-01-06 16:14:52,2004-01-05,PGNX,Prentki Ronald J,Pres,A - Grant,$11.41,220,16492,+1%,"+$2,510",4.0,12.0,19.0,-14.0,PGNX
746,DM,2003-11-05 16:43:45,2003-11-03,PGNX,Scheinberg David A,Dir,M - OptEx,$5.33,10000,11938,+516%,"+$53,300",1.0,-6.0,-5.0,11.0,PGNX
747,DM,2003-11-05 16:43:45,2003-11-03,PGNX,Scheinberg David A,Dir,S - Sale+OE,$17.40,-10000,11938,-46%,"-$174,000",1.0,-6.0,-5.0,11.0,PGNX
748,DM,2003-10-03 20:59:48,2003-09-24,PGNX,Scheinberg David A,Dir,M - OptEx,$5.33,40000,11939,-143%,"+$213,200",2.0,10.0,-1.0,6.0,PGNX
749,DM,2003-10-03 20:59:48,2003-09-24,PGNX,Scheinberg David A,Dir,S - Sale+OE,$19.21,-40000,11939,-77%,"-$768,398",2.0,10.0,-1.0,6.0,PGNX
750,,2003-10-03 20:59:07,2003-10-01,PGNX,Israel Robert J,VP of Medical Affairs,A - Grant,$10.77,2162,8486,+34%,"+$23,285",2.0,10.0,-1.0,6.0,PGNX
751,,2003-10-03 20:58:20,2003-10-01,PGNX,Prentki Ronald J,Pres,A - Grant,$11.94,2582,16272,+19%,"+$30,829",2.0,10.0,-1.0,6.0,PGNX
752,,2003-10-03 20:47:36,2003-10-01,PGNX,Yachmetz Philip K,"VP,GC, Secretary",A - Grant,$9.10,1786,7681,+30%,"+$16,253",2.0,10.0,-1.0,6.0,PGNX
753,,2003-10-03 20:46:30,2003-10-01,PGNX,McKinney Robert A,"VP of Finance, Admin.",A - Grant,$7.15,1509,5955,+34%,"+$10,789",2.0,10.0,-1.0,6.0,PGNX
754,,2003-10-03 20:45:30,2003-10-01,PGNX,Maddon Paul J,"COB, CEO, 10%",A - Grant,$16.81,5895,643835,+1%,"+$99,095",2.0,10.0,-1.0,6.0,PGNX
755,D,2003-09-11 19:24:24,2003-07-03,PGNX,Baker Charles A,Dir,M - OptEx,$5.33,27500,45981,+149%,"+$146,575",3.0,0.0,11.0,16.0,PGNX
756,D,2003-09-11 19:24:24,2003-07-03,PGNX,Baker Charles A,Dir,S - Sale+OE,$15.01,-27500,45981,-37%,"-$412,900",3.0,0.0,11.0,16.0,PGNX
757,D,2003-09-11 19:22:40,2003-07-01,PGNX,McKinney Robert A,"VP of Finance, Admin",A - Grant,$8.76,1254,4446,+39%,"+$10,985",3.0,0.0,11.0,16.0,PGNX
758,D,2003-09-11 19:21:48,2003-07-01,PGNX,Yachmetz Philip K,"VP, GC, Secretary",A - Grant,$9.84,1518,5895,+35%,"+$14,937",3.0,0.0,11.0,16.0,PGNX
759,D,2003-09-11 19:20:52,2003-07-01,PGNX,Maddon Paul J,"COB, CEO, 10%",A - Grant,$15.00,1483,637940,0%,"+$22,245",3.0,0.0,11.0,16.0,PGNX
760,,2003-09-11 19:14:38,2003-07-01,PGNX,Prentki Ronald J,Pres,A - Grant,$11.92,2541,13690,+23%,"+$30,289",3.0,0.0,11.0,16.0,PGNX
761,D,2003-09-11 19:12:12,2003-07-01,PGNX,Israel Robert J,VP of Medical Affairs,A - Grant,$11.12,2018,6324,+47%,"+$22,440",3.0,0.0,11.0,16.0,PGNX
